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Abstract 
The main aims of this study were to explore and identify why traceability 
compliance was poor at the Homerton University Hospital NHS Trust and to 
implement a suitable model to improve it. This study was a multi-stage 
exploration of the various practices of staff involved in the blood transfusion 
chain, both at the Trust and in some other NHS Trusts in the United Kingdom.  
The study explored the reasons for the Trust‟s poor traceability of blood products, 
which eventually led to poor compliance. It identified the risk factors that led to 
poor traceability, explored why some wards had better compliance than others 
and evaluated the direct costs and benefits of wastage. 
The principal aim of these activities was to be able to take an informed decision 
on the development of a new model to improve compliance.  
A quantitative approach was adopted as it made it possible to measure the 
frequency of actions, and this data was used to answer the research questions. 
Data was collected using questionnaires, observations and an audit of 
information extracted from the laboratory‟s information management systems. A 
questionnaire was designed, piloted and sent to all ward managers at the Trust, 
and survey data was analysed using the SPSS statistical package. Some of the 
issues that were addressed and analysed included: staff training in blood product 
collection and administration; knowledge of staff members of the concept of 
traceability compliance; laboratory staff professionalism; ward staff 
responsibilities for traceability compliance; and ward staff attitudes and opinions 
about the traceability model.  
To add rigour to the study, the survey was followed by structured observations at 
the blood collection point and the patient‟s bedside. This data was also analysed 
using descriptive statistics and the results showed that traceability compliance 
was poor in some areas of the Trust. Problems included: the absence of a trainer 
on the ward, lack of education, few transfusion episodes on the wards, variation 
in the method of returning labels to the transfusion department, and poor 
communication between frontline staff and the transfusion laboratory. 
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The study resulted in the implementation of new approaches to the transfusion 
chain in order to improve practice. These included: the appointment of a medical 
laboratory assistant to assist with traceability compliance; the appointment of a 
clinical transfusion nurse specialist to assist with training and ensure safe 
practice on wards; the provision of trainers and clinical supervision on particular 
wards; the development of a competence programme to assess staff involved in 
blood collection and distribution; the development of clinical guidelines; and the 
administration of an annual skills checks for staff involved in the transfusion 
chain. 
Most of the recommendations have been implemented and put into practice. A 
formal audit will be conducted in the future to evaluate their success but to date, 
65% of staff members have passed the annual skills‟ assessment and the 
traceability compliance of the Trust has remained at 100%. 
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1. Introduction 
Blood is one of the world‟s vital substances. The Greeks referred to blood as a 
component of universal order. The Romans felt blood carried a person‟s vital 
essence; the gladiators drank the blood of their fallen opponents. Doctors, from 
mediaeval to Victorian times assumed that blood had a fantastical power; draining 
blood removed evil humour, transfusing blood pacified the deranged (Starr, 2001, 
pp.119-120).  
However, blood is fragile and expensive and has been a heavily traded product 
across the world. The global trade in blood and its products developed in the early 
1970s. Initially, red cells and white cells stayed within national boundaries except 
for Swiss blood that was exported to Greece and the United States. Eventually, 
plasma derivatives became international commodities when the United States 
became the pioneer of plasmapheresis. A darker side of the industry emerged as 
plasma mills appeared in deprived areas of American cities with donation sessions 
from drug addicts and prisoners. Although Europe denounced this practice it 
continued to quietly purchase plasma and its derivatives from America. Other 
plasma mills, located in South and Central America were destroyed in 1978 
(Farrugia, 2006).  
The same, effective, system that was responsible for the collection of blood 
products was equally effective in distributing diseases. Transfusion Transmitted 
Infection became a significant and daily subject of alarm in western countries. Both 
clinicians and politicians were blamed for delivering disease to the population 
rather than preventing it (Feldman & Bayer, 1999, p.268).  
Haemophilia patients became reliant on fractionated plasma in the early 1980s. 
Because they did not need to go to a hospital for a plasma transfusion, some could 
keep fractionated products at home. Easy access to fraction blood products gave 
them a normal life (Feldman and Bayer, 1999, p. 269-270). Consequently, the 
stock of residual plasma products could not meet worldwide demand. However, 
more pooled plasma was needed worldwide than could be supplied from fresh 
blood supplies.  
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Blood and its products (derived from whole human blood or plasma) saves millions 
of lives every year but the entire process of collecting and distributing blood and its 
products depends on the trust and the goodwill of the public. Although some 
adverse events related to blood transfusions may occur immediately, transfusion 
transmitted diseases may not produce any illness for months, or even years. The 
ability to trace the path of the blood from the recipient to the original donor and vice 
versa is an important public health safeguard. In addition, accurate and complete 
record keeping is an essential part of professional practice. 
1.1. Globalisation and blood safety 
Globalisation may be defined as the, “transition from national and regional 
economies to global economies. This includes a nexus of an economic and social 
process where local market and culture are dominated by global market and 
cultures” (Fisher, 2004). It is a consequence of the growing interdependence of 
countries worldwide through an increasing volume of cross-border trading in goods 
and services. 
Data gathered by World Health Organization (World Health Organization, 2006) 
showed that the blood donation rates and the extent of viral testing are dependent 
on economic status (Mattar, 2004). In an ideal and globalised environment, one 
would expect that the challenges faced by the world in terms of the safety and 
supply of blood and its products would be addressed through the free movement of 
blood derivatives. However, the developed world‟s capacity to deal with established 
and emerging blood safety threats, many of which are the results of globalisation is 
lacking (Snyder & Dodd, 2001, p.433). Malaria is the most common transfusion-
transmitted infection worldwide and in non-malarious area is introduced into the 
blood supply via travellers returning from areas where it is endemic. In the United 
Kingdom deferral measures applied to donors returning from such countries are 
considered to provide adequate protection (Snyder & Dodd, 2001). 
Unfortunately the continuing emergence of infectious agents is a feature of 
globalisation. It affects the safety of the blood supply and makes the cross-border 
movement of blood more difficult than in previous times. Nevertheless, the plasma 
industry, where blood products are traded across national borders is one example 
of the continuing global nature of the business. The reaction of humans to the 
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pressures of globalisation is responsible for many of the current challenges posed 
by trade-related infections (Kimball, Arima & Hodges, 2005, p.2). 
Higher levels of traffic in goods and people have affected both blood safety and 
supply in many ways. The increasing movement of plasma products has eroded 
some of the historical barriers between countries. Developed countries are 
strengthening the blood safety infrastructure through the development of new tests 
and pathogen elimination techniques (World Health Organisation, 2006). Many of 
these measures are the result of trends initiated by pharmaceutical manufacturers 
and in the healthcare sector although in general such processes have been 
restricted to, and focused on, rich countries (Kreil et al., 2003, pp.1023–1026). 
Variant Creutzfeldt Jakob Disease (vCJD) is a degenerative disorder that was first 
recognized in 1996 in the UK. It is caused by bovine spongiform encephalopathy 
(BSE) contaminated meat. From October 1996 to March 2011, 175 cases of vCJD 
have been reported in the United Kingdom, 25 in France, five in Spain, four in 
Ireland, three each in the Netherlands and the United States, two each in Canada, 
Italy and Portugal and one each in Japan Saudi-Arabia and Taiwan. vCJD is a new 
disease and the risk of transmission has been a major concern to blood services 
since its discovery. The precautionary measures taken since 1999 include the 
removal of white cells believed to contain much of the infectious agent-prions 
(McClelland et al., 1996).  
The first incident of the contamination of blood by Hepatitis B was seen in 1982 in 
patients with haemophilia who had received blood fractions as therapy for their 
clotting disorder. These products were produced from the pooled plasma from a 
large number of donors, which was normal procedure at this time. Until then, the 
potential contamination of blood products with infectious diseases had not been 
seen as a risk. Since then, the response to Acquired Immune Deficiency Syndrome 
(AIDS) that affected government policies and the reputation of the medical 
profession has been called the blood scandal (Feldman,1999). 
Canada, France, Japan, and the United States all contributed to the AIDS scare. All 
four countries were self-sufficient in whole blood and blood components from 
voluntary donors although France relied on prisoners as volunteers and Canada 
and Japan imported blood fractions for haemophiliacs. Haemophiliac patients 
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organized themselves differently in different countries and this affected the 
pressure that they were able to exert on the political structure. They gained most 
recognition in Japan in the 1980s and received substantial compensation. In 
Canada and France they accepted compensation schemes offered by the 
government (Baldwin, 2005). 
The French blood system was deeply involved in the scandal. Perhaps due to pride 
in the purity of French blood, the downfall of the system was its involvement in  
more than half of the blood-transmitted AIDS cases in Europe. In 1991, an internal 
government document revealed that the early success of heat treatment of factor 
VIII was ignored. The distribution of older, unheated, contaminated fractions 
continued from some blood centres in France and was justified by the cost. In 
1992, the Director of the National Centre in Paris was sentenced and jailed, an 
event that is now widely believed to be a miscarriage of justice (Schmidt, 2006). 
In Japan, as in France, the driving force behind the AIDS blood scandal was the 
effect of infected blood fractions on the nation's haemophiliac population. At this 
time commercial operators took control of plasmapheresis and Japan's 
corporations guaranteed plasma collections. It was the product of this unholy 
alliance that brought HIV to Japan. The problem set the stage for the most 
prominent health scandal in Japan‟s history. Further evidence of failure was found 
in the continued use of unheated plasma long after the heat treatment of plasma 
was mandatory in the United States. The principals involved were charged with 
murder (Schmidt,2006).  
The Canadian blood system combined the problems seen in France of a loosely 
controlled and overly-trusted source of whole blood, and contaminated plasma from 
American blood. The government had left the regulation of the blood system to the 
Canadian Red Cross and the therapy for haemophiliacs was being met by plasma 
processed in the United States. The public became aware of the disaster as the 
untreated plasma spread among the haemophiliac population in Canada. The Red 
Cross‟s response was slow and when the government finally decided to fund blood 
testing, the decision came seven months later than in the United States. The 
Canadian Red Cross later filed for bankruptcy and removed itself from all activities 
associated with the blood system. A new National Canadian Blood Service was 
created to do the work of the Red Cross. Consequently, Canada, France and 
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Japan‟s blood system have been constructed to protect the public from the 
previous mistakes (Gallo & Montagnier, 2003, pp. 2283–2284). 
The United States carried out a major analysis of its blood programme in 1972 
following the hepatitis problem. Although the United States was the country in 
which the new disease (that turned out to be HIV) was first seen in 1990s.The 
blood scandal resulted in lesser political and social upheaval than in Canada, 
France and Japan. The peculiarities of United States liability laws required patients 
to file for compensation in their local jurisdiction (Baldwin, 2005). Blood centres in 
the United States were protected by blood shield laws passed during the hepatitis 
era which absolved them of any responsibility if they had carried out the required 
testing. Although court rulings always found against the patients, many cases never 
reached the courts. It was not until 1995 that infected haemophiliacs were 
compensated by the federal government. 
Studies by Glynn et al. (2003) and Ling (2010) claimed that blood is safer than 
ever. However, safety culture was not enforced during the hepatitis era. The 
Department of Health and Human Services in the United States have implemented 
a comprehensive safety vigilance system to address the threat from unknown and 
emerging infectious sources (Busch et al., 1999). Blood is not entirely safe, but 
neither is it our most dangerous drug. Like many good things, it comes with risks. 
1.2. Epidemiological monitoring of donors 
The purpose of epidemiology monitoring of donors is to gain a better understanding 
of the various parameters that lead to donor exclusion either on medical grounds or 
self-exclusion. In the United Kingdom (UK), data must be recorded in the national 
blood collection surveillance registry. In 2010, the rate of infection among UK blood 
donors was low, with approximately 11.7 infected donations per 100,000 tested. In 
2010, 2.5 million donations were tested, of which 286 tested positive for a marker 
of infection. Four out of five infections detected came from new donors (HPA,2011). 
The residual risk of viral infection can be estimated from data measuring the 
number and percentage of seropositive donations in previous years, the prevalence 
of seropositive donors, the length of the pre-seroconversion window period, the 
sensitivity of the screening test and the probability of blood components being 
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contaminated. These models have made it possible to identify a number of 
preventative measures. The evaluation of blood donation safety can also be based 
on the follow-up of recipient cohorts by assessing residual risks in a given 
population, such as in multi-transfused patients (Debeir et al., 1999, p.81). 
1.3. Haemovigilance 
Haemovigilance is defined as, “a system of surveillance and alarm, ranging from 
the collection of blood products to the follow up of recipients, to gather and assess 
incidents resulting from the transfusion of the blood products”. The main goal of 
haemovigilance is to prevent the recurrence of incidents by identifying their causes 
(McClelland et al., 1998). Haemovigilance contributes to the process of maintaining 
and improving transfusion safety. It grew out of government-driven reviews of the 
organization of transfusions following the HIV transmission scare in the early 1980s 
(Faber, 2002). The mandatory reporting at a national level of any undesirable 
events related to blood transfusion was introduced in the United States in 1975.  
The concept was first implemented in Europe in 1988 by Belgium, Denmark, 
France, Luxembourg, the Netherlands, Portugal, Spain and Switzerland, with a 
simple objective of being able to share alerts (Herve, 2002, p.30). In 1995, the 
member states of the European Union indicated a need for countries to establish a 
haemovigilance system. This culminated in the European Blood Directive (Faber, 
2004). The directive states that, “member states shall ensure that there is a system 
in place to collect, collate and transmit information about adverse reactions and 
events related to the collection, testing, processing, storage and distribution of 
blood and its components to the competent authority”. Consequently, most 
European countries have had an established system for haemovigilance since 
2010. (de Vries et al., 2011). 
The European Haemovigilance Network (EHN) was established in1998 and the 
International Haemovigilance Network (IHN) was formed from the EHN in 2009.   
Table 1-1 gives an overview of the National Haemovigilance Network in Europe in 
2010.  
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Table 1-1 Overview of national haemovigilance systems in the European Union.  
Member States  
of European Union 
Haemovigilance  
 
Status Body responsible 
Austria Established Mandatory OBIG 
Belgium Established Voluntary Red Cross 
Denmark Established Voluntary DART 
Finland Established Voluntary Red Cross 
France Established Mandatory AFSSAPS 
Germany Established Mandatory PEI 
Greece Established Voluntary SKAE/PEEL 
Ireland Established Voluntary NHO 
Italy Established Voluntary ISS 
Luxembourg Established Voluntary Red Cross 
Netherlands Established Voluntary TRIP 
Portugal Building up Mandatory IPS/MoH 
Spain Building up Voluntary SSTM/MoH 
Sweden Established Voluntary SATM/Hospitals 
United Kingdom Established Voluntary SHOT/SABRE 
Greece Established Voluntary SKAE 
Source: Updated from de Vries, Faber and Strengers, 2011 
Key: AFSSAPS-Agence Francaise de Securite Sanitaire de Produits de Sante; DART-
Danish Registry for Adverse Reaction in Transfusion; IPS-Instituto Portugues do Sangue; 
ISS-instituto Superiore de Sanita; NHO-National Haemovigilance Office; OBIG-
Osterreeischiches Bundes-Institut fur Gesundheit; PEI-Paul Ehrlich-Institut; SATM-Swedish 
Association for Transfusion Medicine; SHOT-Serious Hazard of Transfusion; SABRE - 
Serious Adverse Blood Reaction and Events; SKAE- Hellinic Coordinating Haemovigilance 
Centre; SSTM-Spanish Society of Transfusion Medicine; MoH-Ministry of Health. 
In Europe, the French and British systems are different. The French 
haemovigilance system was established in 1994 (Andreu, Morel & Forestier, 2002), 
it is nationwide and there is a legal obligation to report any untoward effects related 
to blood transfusion (Andreu, Morel & Forestier, 2002). It must meet three 
objectives at local and national level: (1) identify risks and related factors and 
monitor these risks; (2) assess the relevance of medical indicators present in 
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individuals that wish to donate blood and (3) at the transfusion level, estimate the 
incidence of transfusion-induced side-effects in recipients (de Vries et al., 2011). 
In the UK, the Serious Hazards of Blood Transfusion (SHOT) was launched in 
1996. Unlike France, only serious adverse reactions must be reported to SHOT on 
a voluntary basis (Williamson, 2002). The participation of UK hospitals in 
haemovigilance has improved since 2009 with an 85% increase in the number of 
reports submitted in 2010. At the same time, the number of non-reporting hospitals 
and trusts has fallen.  
1.4. Blood transfusion in the UK 
Over a 15 year period (1996-2011) more than 36 million blood components were 
provided by the United Kingdom Blood Services and 4,334 untoward incidents 
were analysed. Table 1-2 is a summary of all blood products issued 1999–2011 by 
regional UK transfusion centres. It shows a downward trend in blood products 
issued due to the postponement of blood donations during the influenza season 
and measures taken to exclude potential donors to reduce the incidence of vCJD. 
Table 1-2 Blood products issued by UK blood services 1999-2011. 
Year Blood products issued 
1999-2000 3,446,855 
2000-2001 3,426,782 
2001-2002 3,404,865 
2002-2003 3,399,988 
2003-2004 3,340,221 
2004-2005 3,103,200 
2005-2006 3,002,797 
2006-2007 2,914,228 
2007-2008 2,845,459 
2008-2009 2,903,760 
2009-2010 2,898,425 
2010-2011 2,956,351 
Source: Serious Hazards of Transfusion, 2011, p.2 
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In 2000, blood transfusions were estimated to cost the NHS £898 million, 
representing a 256% increase since 1994/1995. The introduction of additional 
technique for the screening of infections such as HIV, HTLV, HepB, HepC and 
malaria contributed to the rise in cost. The estimated cost for an adult transfusion 
was £635 for red blood cells, £375 for plasma, £347 for platelets and £834 for 
cryoprecipitate (Varney, 2003). 
The most frequent hazard reported by the Serious Hazards of Blood Transfusion 
(SHOT) is the transfusion of an incorrect blood component (Serious Hazards of 
Transfusion, 2011). 
Table 1-3 Blood transfusion errors in the UK blood supply 1996-2011.  
Year Number of errors 
1996-1997 63 
1997-1998 107 
1998-1999 131 
1999-2000 188 
2000-2001 173 
2001-2002 302 
2003 324 
2006 1279 
2007 1341 
2008 2177 
2009 2475 
2010 1464 
2011 1815 
Source: Serious Hazards of Transfusion, 2011, p.16 
Figure 1.1 shows the breakdown of errors reported to SHOT in 2011. Incorrect 
Blood Component Transfused (IBCT) incidents accounted for 13.6% of errors 
reported, even taking into account under-reporting. IBCT is a preventable error if 
corrective and preventive actions are put in place. 
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Figure 1.1 Summary of blood transfusion errors 2011 
Key: ATR-Acute transfusion reaction, TACO-Transfusion associated circulatory overload, 
TRALI-Transfusion related acute lung injury, PTP-post transfusion purpura, HTR-
Haemolytic Transfusion reaction, HSE- Handling & Storage Error, IBCT-Incorrect blood 
component transfused, TAD Transfusion Associated Dyspnoea, IU- intrauterine transfusion.  
Source: Serious Hazards of Transfusion, 2011, p.16 
The number of incident reports has risen in subsequent year this can be suggestive 
of open culture in reporting and the activities of the Medicine and Healthcare 
Products Regulatory Agency – the regulatory body in the UK. However, many UK 
hospitals still do not submit reports despite legal requirements. Northern Ireland 
and Wales reported more incidence than Scotland and England which suggest that 
Northern Ireland and Wales have a high incidence detection level of reporting.  This 
is a major concern from both professional and regulatory viewpoints (Serious 
Hazards of Transfusion, 2009). 
Table 1-4 Total number of reports per 10,000 components 2007-2011 
 2007 2008 2009 2010 2011 
England 4.6 7.7 8.1 8.9 10.9 
Northern Ireland 6.6 10.0 10.5 16.0 21.1 
Scotland 3.1 5.4 6.8 10.6 14.3 
Wales 8.4 12.3 19.6 15.2 16.4 
United Kingdom 4.8 7.8 8.5 9.5 11.6 
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Source: Serious Hazards of Transfusion, 2011, p.8 
In 1998, there were 33 suspected cases of transfusion-transmitted infection (TTI) 
reported by blood centres and hospitals in the UK. The investigation of the blood 
products involved showed that there were four incidents of contaminated units of 
platelets that were proven to have transmitted bacterial infection to six recipients. 
By 2008, there were no proven cases of viral or protozoan transmission, although 
serious complications from bacterial contamination of blood components remained 
a challenge for the UK Blood Services (Serious Hazards of Transfusion, 2011).  
Table 1-5 shows the number of infected recipients identified and their outcome 
from 1996-2011.  
Table 1-5 Number of infected recipients and their outcome 1996-2011. 
 Number of infected 
recipients identified 
Death due  
to infection 
Major  
morbidity 
Minor  
morbidity 
Bacteria 43 11 28 4 
HAV 3 0 2 1 
HBV 11 0 11 0 
HCV 2 0 2 0 
HIV 4 0 4 0 
HEV 1 0 0 1 
HTLV 2 1 1 0 
Malaria 2 1 1 0 
vCJD 4 4 0 0 
Prion 2 1 1 0 
Total 74 18 50 6 
Source: Source: Serious Hazards of Transfusion, 2011, p.131 
Key: HAV-Hepatitis A virus, HBV-Hepatitis B virus, HCV-Hepatitis C virus, HIV-Human 
immunodeficiency virus, HEV-Hepatitis E virus, HTLV-Human T cell leukaemia virus, vCJD-
Variant Creutzfeldt Jakob disease. 
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The knowledge of ABO blood group system in the 18th and 19th century was 
minimal which led to a lot disasters. According to (Starr, 2001). Further blood 
transfusion procedures led to haemolytic episodes and deaths in the early part of 
the 18th century and this eventually resulted  in a ban for over a century. The 
discovery of ABO blood group systems in the early part of the 20 th century 
minimised haemolytic episodes but  transfusion transmitted infections became a 
major concern due to global trade of blood products and inadequate screening 
(Fisher, 2004). 
Blood transfusion in the 20th century had informed many of the decisions, initiatives 
and guidelines in the 21st century and these are discussed fully in the following 
sections 1.5. Following the increased of transfusion transmitted hepatitis, the term 
haemovigilance was coined in the United States in the early 1970s to address the 
threat to patient safety and tighten regulations on the use of blood products. This 
led to the introduction of a robust quality management system for blood transfusion 
in order to protect the patient and the public.  
This concept was launched in Europe in 1988 and the French established a 
haemovigilance programme in 1994. An incident in which the use of contaminated 
blood led to the import and distribution of contaminated plasma products to 
haemophiliacs in the United Kingdom undermined the government‟s ability respond 
to the threat and led to immeasurable damage to the National Blood Service.  
Although the European Blood Directive had indicated the need for haemovigilance, 
the idea did not immediately take off. Consequently, the Serious Hazards of 
Transfusion (SHOT) scheme was not launched until 1996.  
The launch of SHOT was the starting point for haemovigilance in the United 
Kingdom. Initially not all NHS Trusts fully participated in this scheme; few incidents 
were reported and the data that was collected was not collated. Nevertheless, 
improvements in quality assurance of blood and blood product testing became 
clear as SHOT began to publish annual reports.  
The introduction of the European Union Directive in 2002 and Blood Safety and 
Quality Regulations (BSQR) in 2005 brought a big change in the collection, 
storage, distribution, and traceability of blood products in the United Kingdom.  The 
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BSQR became law in 2005 and failure to comply was considered to be a criminal 
act.  
The risk of mistransfusion became greater in the 21st century, see Page 34 “The 
risk of mistransfusion was found to be greater than the risk of transmission of HIV 
or HCV (Dzik, 2002, p.1190).” SHOT,(2011,p.16) also emphasized of the incidence 
of incorrect blood component transfused in the U.K. Mistransfusion can also be due 
to poor control or knowledge of the collection, storage, distribution and traceability 
of blood products. 
My research design was to explore and identify why traceability compliance was 
poor within the Trust and to implement a suitable model to improve traceability 
compliance within the Homerton University Hospital NHS Trust and to enhance 
patient‟s safety within the transfusion chain. 
 
 
1.5. The regulatory framework 
European Commission Blood Directives 2002/98/EC (European Union Directive 
2002/98/EC) and 2004/33/EC were transposed into the United Kingdom‟s Blood 
Safety and Quality Regulations 2005 (Statutory Instruments 2005/50, 2005/1098 
and 2006/2013) and became mandatory in the same year. The law imposed new 
requirements on all hospital transfusion laboratories and clinical transfusion 
process in the UK. The regulations required “unambiguous traceability” of all blood 
and blood components from a donor to patient, or the final destination of all blood 
and its components if not transfused. The final destination of every blood 
component has to be retained and be made available for 30 years (Blood Safety 
and Quality Regulations, 2005). 
The Council of Europe defined traceability as, “the ability to identify the actual 
recipient of every component released and, conversely, the ability to identify all 
blood donors involved in the transfusion given to a patient. The active return of 
information from the clinical area to the blood transfusion department after the 
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transfusion act is necessary to provide complete and reliable information about the 
fate of the given blood component” (Council of Europe, 2003). 
European Union Commission Directives 2005/61/EC and 2002/98/EC (2005), also 
required the full traceability of blood and blood components. Blood establishments 
and hospitals are required to implement a system that permits the identification of 
each unit of blood component and its final destination. A system that has proved 
effective in the UK is the so-called „bag & tag‟ label system. When a unit of blood is 
prepared for a patient, a computerised laboratory system prints a tag. This includes 
information that identifies the patient and two traceability labels bearing the 
donation number. 
It is important to understand the reasons behind the urgency of this current move to 
the traceability of blood and its products. The emergence of transfusion transmitted 
diseases has damaged trust in the blood establishment around the world and a 
survey of various haemovigilance systems indicated that errors in the blood 
transfusion chain, from the initial recipient identification to final blood administration 
occur in about 1 in 1000 events (Pagliaro & Rebulla, 2006). Specific tools have 
been developed to prevent the potentially fatal consequences of such mistakes. 
These include barcoded patient identification bracelets and mechanical and 
electronic locks that can allow full audit trail of all transfused blood products. 
Although a number of studies have demonstrated the effectiveness of these 
systems, they have not been widely adopted because of financial constraints.  
1.6. Organisational and professional drivers of   
BSQR 
A patient is entitled to be cared for by healthcare professionals with relevant and 
up-to-date skills and expertise (Kennedy, 2001, p.322). For the general public, this 
means that they can be also involved in the planning, organisation and delivery of 
healthcare.  
1.6.1. Serious Hazards of Transfusion (SHOT) 
Serious Hazards of Transfusion is an independent, professionally-led 
haemovigilance scheme that was launched in 1996 and collects data on serious 
sequelae caused by the transfusion of blood components. The data collected 
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contributes to improvements in the safety of the blood transfusion process, informs 
policy within the transfusion services in the UK and helps in the production of 
clinical guidelines for the use of blood components.  
1.6.2. Clinical governance 
Clinical governance consists of the processes healthcare organizations use to 
monitor and improve the quality of clinical services delivered within the healthcare 
system. It was introduced in 1998 as part of the UK government‟s ten year plan to 
improve the overall standard of clinical care (Department of Health, 1998).  
  
Figure 1.2. The pillars of clinical governance 
Source: National Audit Office, University of Birmingham (2007). 
The introduction of clinical governance was aimed at improving the quality of 
clinical care at all levels of provision. It was seen as a way of addressing concerns 
about the quality of health care following well-documented variations in standards. 
It necessitates a more widespread adoption of the principles and methods of 
continuous quality improvement initially developed in the industrial sector and later 
applied to the healthcare sector (Berwick, 1989). Table 1-6 summarises the 
infrastructure, systems and processes related to clinical governance. 
Clinical Care 
Clinical 
effectiveness and 
practice 
Evidence-based 
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Clinical risk 
management 
Incident 
management 
system 
Adverse event 
monitoring 
Patient 
experience 
Patient 
satisfaction 
Patient 
complaints 
Patient‟s 
rights 
Professional 
Development 
Management 
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Skill updating 
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Table 1-6 Infrastructure, systems and processes related to clinical governance 
External drivers for clinical 
governance 
Department of Health Inspection and review 
mechanism 
Clinical guidelines (NICE, 
SIGN) 
Trust/Health boards and 
primary care 
Regulatory bodies: CPA, 
MHRA 
National Service Framework Chief Executive Commission for Health 
Improvement 
National Patient Safety Agency Clinical governance Clinical Standards Board for 
Scotland 
Blood Safety Quality 
Regulations 
Clinical governance sub- 
committee 
MHRA 
Source: RCN resource guide, 2003. 
Key: NICE - National Institute for Clinical Excellence, SIGN - Scottish Intercollegiate 
Guidelines Network, CPA - Clinical Pathology Accreditation, MHRA - Medicine and 
Healthcare products Regulatory Agency 
National Health Service research and development programmes have helped to 
gather the evidence needed to inform clinical decision-making and service 
planning. The move to evidence-based practices has influenced many healthcare 
systems in the world. The most obvious contribution is the introduction of 
technology that enables access to specialist databases and professional 
knowledge. Evidence-based work in clinical practice has been centred on specific 
interventions and clinical policies. However, clinical governance is expected to 
address the question of how good practice in one service can be transferred to 
others (Oxman et al., 1995). 
1.6.3. National Patient Safety Agency  
The National Patient Safety Agency (NPSA) set a target of reducing the number of 
inadvertent incompatible transfusions over 3–5 years and identifying effective local 
solutions to wrong blood events at the bedside. The Right Patient, Right Blood 
project was a joint initiative between the NPSA, the Chief Medical Officer's National 
Blood Transfusion Committee (NBTC) and SHOT. The purpose of the project was 
to develop and evaluate the complexities of the transfusion chain to ensure that the 
right patient received the right blood (Stainsby, 2005, pp.8–12). A labelling system 
was selected as an initiative for testing and development; it implemented labels 
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bearing a unique number that provided an additional link between the patient and 
the blood product to be transfused (National Patient Safety Agency, 2006).  
1.6.4. The UK Transfusion Laboratory Collaborative 
The UK Transfusion Laboratory Collaborative was established in 2006 in response 
to a SHOT report. The report identified that 30-40% of wrong blood events 
originated from hospital blood transfusion laboratories with a disproportionate 
number of events occurring outside core hours (Serious Hazards of Transfusion, 
2001, p.9). The Collaborative was formed between SHOT and the Institute of 
Biomedical Sciences (IBMS), but extended to other key professional groups 
involved in laboratory medicine.  
The Collaborative has produced recommendations on minimum standards for 
hospital transfusion laboratories, which address training, staffing, technology and 
competency (Chaffe et al., 2009). The recommendations were intended to 
encourage the effective and appropriate use of technology within the framework of 
legislative requirements, help hospital trusts to achieve minimum standards of 
proficiency set by the Health Profession Council (HPC) and meet the requirements 
of Blood Safety and Quality Regulations (Blood Safety and Quality Regulations, 
2005).The overall aim was to reduce blood transfusion laboratory errors by 50% in 
three years. The impact on transfusion laboratories was monitored through existing 
MHRA inspections and reporting to SHOT.  
1.6.5. Better Blood Transfusion 
The Better Blood Transfusion circular (Department of Health, 1998a) was sent to all 
NHS Trusts in the UK that undertook blood transfusions. It asked them to 
participate in the SHOT scheme and fulfil MHRA requirements for the reporting of 
Serious Adverse Blood Reaction and Events (SABRE). It also emphasized the 
need for training for laboratory staff and giving them the power to review requests 
for blood transfusions in order to reduce the inappropriate use of blood.  
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Table 1-7 National Comparative Audit on Better Blood Transfusion. 
 2003 2004 2006 2008 2010 
Completion of the questionnaire 122/259 160/169 156/170 153/166 153/162 
HTC met 3 times during last year 98% 99% 97% 97% 94% 
HTC includes 2 representatives 97% 91% 96% 97% 94% 
Clear report to the Chief Executive 87% 89% 94% 97% 95% 
Trusts employing a transfusion nurse 50% 68% 92% ND ND 
Trusts employing a consultant for blood 
transfusion 
74% 83% 90% ND ND 
Training 
Medical staff induction 66% 80% 87% 89% 92% 
Medical staff annual update 25% 31% 54% ND ND 
Nursing staff induction 70% 78% 83% 96% 95% 
Nursing staff update 46% 28% 88% ND ND 
Phlebotomist induction 70% 80% 74% 93% 91% 
Phlebotomist update 33% 41% 58% ND ND 
Porter induction 50% 57% 69% 79% 76% 
Porter update 30% 43% 58% ND ND 
Policies 
Transfusion process 97% 98% 98% 100% 100% 
Use of platelets 75% 68% 78% 74% 78% 
Use of red cells in critical care 44% 46% 70% 67% 64% 
Use of red cells in surgery 34% 39% ND 61% 54% 
Percentage of Trusts indicating that staff involved in administering blood have received 
competency-based training and assessment (ND = No Data) 
>91% ND ND ND 2% 22% 
>50% ND ND ND 12% 76% 
Trusts using barcodes or other 
electronic systems for blood transfusion 
ND ND ND 
 
ND 16% 
Trusts using an electronic blood fridge 
system for blood tracking. 
ND ND ND ND 42% 
Participation in SHOT 99% 99% 95% 97% 99% 
1.6.6. European Blood Safety Directives  
The European Council, in its resolution of 2nd June 1995 on Blood Safety and 
Sufficiency in the European Community invited the European Commission to 
submit proposals for the development of a blood strategy. The main aim was to set 
high standards of quality and safety in blood transfusion taking into account the fact 
that the organization and regulation of blood transfusion is very different in different 
European countries. The Directive aimed to harmonise these differences in order to 
improve the level of quality and safety in blood transfusion across the European 
Community (Faber, 2004). 
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The European Union Directives (2002/98/EC and 2004/33/EC) set standards for 
the quality and safety of blood collection and testing of human blood and blood 
components. Directive 2002/98/EC began as the European Blood Directive 
regulation. It covers the following areas: 
a) Describes the content of the European Blood Directive, 2002/98/EC. 
b) Describes the technical requirements addressed in the Directives to be 
published as European Commission Directives. 
c) This article also described the potential impact of the legislation related to 
blood transfusion activities in the Member States of the European Union 
and also on its strengths and weakness. 
The European Blood Safety Directives became law in the UK on the 8th February, 
2005 in the form of the Blood Safety and Quality Regulations 2005. The UK Health 
Secretary is the designated competent authority for the Directive. The regulation 
applies to the collection, testing, storage and distribution of blood and blood 
component when they are intended to be used by humans. 
1.6.7. UK Blood Safety and Quality Regulations 
The Blood Safety and Quality Regulations 2005 require the full traceability of blood 
and blood components from the point of receipt of the blood or blood components 
by the hospital. The confirmed final destination of blood components received by 
the site must be retained in a readily-available format, recoverable for thirty years. 
The Medicine and Health Products Regulatory Agency (MHRA) was designated as 
the competent authority in the UK under the legislation. The MHRA is a 
government agency whose role is to enhance and safeguard the public‟s health by 
ensuring that medicine and medical devices meets acceptable standards of safety 
and they work. The MHRA aims to safeguard public health by: 
 Ensuring, through regulation, that medicine and devices have an acceptable 
balance of risks and benefits. 
 Helping people to understand the benefits and risks of medicines and 
devices. 
 Encouraging and helping the development of medicines and devices that 
will contribute to health. 
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The regulations required that the competent authority ensure compliance with the 
relevant regulations. To achieve this, the MHRA developed a compliance report 
which all hospitals with blood banks must complete annually. Hospital blood banks 
must provide details of their accreditation status, staffing levels, traceability and 
quality management system within the department. The report is reviewed and an 
on-site visit takes place if non-compliances are identified. The MHRA has also 
established a system of reporting and recording transfusion-related incidents 
known as Serious Adverse Blood Reactions and Events (SABRE).  
1.6.8. Clinical audits and professional standards 
The power of audits in the quality improvement process is well recognised, which is 
reflected in the standards of a number of professional health organisations. The 
Health Professions Council‟s Standards of Proficiency for Biomedical Scientists 
(Health Professions Council, 2004) state that the skills required for application of 
practice are:  
“To be able to audit, reflect on and review practice you must understand the 
principles of quality control and quality assurance, be aware of the role of audit and 
review in quality management, including quality control, quality assurance and the 
use of appropriate outcome measures, be able to maintain an effective audit trail 
and work towards continual improvement, participate in quality assurance 
programmes, where appropriate, understand the value of reflection on practice and 
the need to record the outcome of such reflection and recognise the value of case 
conferences and other methods of review.” 
The General Medical Council’s Good Medical Practice states:  
“You must work with colleagues and patients to maintain and improve the quality of 
your work and promote patient safety. In particular, you must take part in regular 
and systemic audit. take part in systems of quality assurance and quality 
improvement and respond constructively to the outcome of audit, appraisals and 
performance reviews, undertaking further training where necessary” (GMC,2011). 
The Nursing and Midwifery Council’s standards of conduct, performance and 
ethics (Nursing and Midwifery Council, 2009) requires registrants to provide a high 
standard of practice and care at all times, and states, 
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“You must work with colleagues to monitor the quality of your work and maintain 
the safety of those in your charge and also take part in appropriate learning and 
practice activities that maintain and develop your competence and performance. 
Traceability and identification management techniques increase interest in 
healthcare is well emphasized.”  
Some other performance management and improvement processes are: 
 The Healthcare Quality Improvement Partnership (HQIP) 
 NHS Litigation Authority Risk Management Standards 
 The Healthcare Commission 
1.7. Transfusion safety 
Although the potential untoward effects of blood transfusion have been recognized 
almost since the practice began, no systematic data was collected for decades 
despite the publication of several reports (Herve et al., 2000). The major steps in 
the clinical transfusion process involve obtaining a patient sample, labelling it and 
submitting it to the transfusion laboratory for cross-matching (Figure 1.3). The 
intention is, “getting the right blood, to the right person, at the right place, at the 
right time” (McClelland et al., 1996). Eliminating errors in matching patients with 
their care is one of the key ways of improving safety. Although there are no 
accurate figures on the frequency or cost of mismatching errors, research has 
indicated that they form a significant proportion of healthcare errors (National 
Patient Safety Agency, 2005). 
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Figure 1.3 Steps in the transfusion chain. 
Hospitals must be able to show that their blood transfusion practices are safe, 
clinically effective and efficient. This requires a paradigm shift in favour of a 
strongly founded belief that quality, safety and effectiveness must be built into the 
blood transfusion process, total process control and procedures that prevent errors. 
1.7.1. Recipient recall programmes 
Recipient recall programmes refer to the practice of notifying a large group of 
recipients who have been exposed to an infectious agent at the time of the 
transfusion (Busch, 1991, p.655) and who have been identified as infected with a 
specific disease. It requires hospital blood transfusion services to trace transfusion 
records in order to identify the individuals that received the specific component. 
The recipient is usually notified of their potential risk by their clinician. Further tests 
are carried out after counselling. Current regulations require the recall of donors 
who have been identified as infected with a blood-borne infection. The 
requirements specifying which recipients must be informed are complex because of 
the evolution of Hepatitis C screening and confirmatory tests (Goldman et al., 
1996). 
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1.7.2. Methods to identify blood transfusion incidents 
Human error is routinely blamed for accidents in healthcare. Humans tend to rush 
to judgement following an incident and, all too often, blame the person most 
associated with the accident. This prevents the discovery of the whole story (Cook, 
Wood & Miller, 1998).  
Table 1-8 shows the results of a study that examined a series of events and 
departures from safe practice which were influenced by the working environment 
and the wider organisational content (Vincent, Stanhope, & Crowley-Murphy, 
1999). 
Table 1-8 Predictive Human Error Analysis (PHEA) technique 
Planning error Checking error Communication error 
Incorrect plan executed 
Correct but inappropriate plan 
Correct plan but too soon or 
late 
Check omitted 
Check incomplete 
Right check, wrong 
blood 
Information not communicated 
Operating error Selection error Retrieval 
Operation too long or short 
Operation inappropriate 
Selection omitted 
Wrong selection made 
Information not obtained 
Wrong information obtained 
Information retrieved 
incomplete 
Source: Embrey, 1992; Hollnagel, 1998 
A number of methods have been identified to reduce the contribution of human 
errors to the risk of blood transfusion.  
Table 1-9 shows some common methods used for error identification and these are 
reviewed in the following paragraphs. 
Table 1-9 Error identification methods; advantages and limitations 
Method Advantages Limitations 
Observation/Audit Accurate method to identify 
performance of individual 
Labour intensive and limited 
lasting value 
Accident analysis This is used to determine 
error rate and understand 
misadventures 
Limited by hindsight and 
delay in investigation. Often 
lack information. 
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Simulation An accurate way to assess 
team and individual 
performance and decision 
making 
Difficulty to create and can 
only simulate some aspects 
of the transfusion. 
Record review Standard method of 
documenting outcome and 
many processes 
Only as good when the 
information is recorded. 
Event reporting Captures near misses events 
and deviations as perceived 
by individuals. Gives 
perspective of individual 
involved. 
Subject to underreporting 
because individual do not 
feel comfortable. 
Source: Kaplan et al., 1998 
One approach is direct observation by skilled observers in the actual operating 
environment. Schulman (2004, p.652) developed a multidisciplinary approach to 
quality assurance and improvement directed at reducing patient identification error. 
The authors found in-service education to be effective in increasing compliance 
and reducing the risk of error. However, the observation itself may have altered the 
circumstances studied. 
A second approach is accident analysis. This approach has been extensively used 
in aviation by the National Transportation Safety Board (Nagel, 1988). However, 
hindsight bias and incomplete data can lead to distortion of the facts. Despite this 
limitation, accident analysis has also been an important source of information in 
blood transfusion incidents. For example, Mummert and Tourault (1993) reviewed 
150 transfusion-associated fatalities from 1990–1992. They concluded that nearly a 
third of fatalities could have been prevented by full adherence to standard 
operating procedures. Interestingly, a failure to follow procedures is also 
responsible for a third of major air carrier accidents Nagel (1988) who also stressed 
the need for models of human error to be used in conjunction with error data 
collection and classification. The management of error to limit adverse outcomes or 
unplanned effects is now recognised to be of fundamental importance in system 
design and training (Reason, 1990). Although the importance of this has been 
recognised in transfusion medicine it has not been fully implemented in all critical 
areas of operation.  
A third approach is the study of error through laboratory simulation. This approach 
is useful as it enables the simplification and control of variables; although 
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simplification may itself be an important shortcoming in understanding inherently 
complex situations (Nagel, 1988). Taswell et al. (1974, p. 491) modified the 
conditions of work by introducing known errors and provided positive feedback 
when they were found. The blood transfusion department involved in the study not 
only improved the detection rate of introduced errors, but also increased the 
detection of real, previously undetected errors, from four in the first three months of 
the study to 73 in the final three months. 
A fourth approach to error identification is the review of records. This has been a 
traditional way to perform quality assurance checks and document patient 
outcomes. Patient records document actions performed and can highlight missing 
information. The audit of records against predetermined criteria can be a valuable 
way to identify errors or near misses. Classen et al. (1991, p.301) successfully 
used a sophisticated automated hospital information and record system to identify 
adverse drug events that would otherwise not have been reported.  
A fifth approach is the event report, including self-reporting. In aviation, despite 
excellent record keeping, human error is identified as a casual factor in more than 
half of all airline accidents. More than 250,000 reports have been archived, 
analysed and made available for research and study by interested professionals 
and regulatory bodies (Nagel, 1988). This no-fault, confidential, voluntary, self-
reporting system enables pilots and controllers to report all non-calamitous 
mistakes, including caught errors. Confidentiality and immunity from prosecution for 
non-criminal acts are other important features of this or any system intended to 
capture operational errors. The no-fault, confidential nature of the system has led to 
an increased frankness in reporting and the provision of invaluable data (Classen 
et al., 1991).  
1.7.2.1 Haemovigilance 
Haemovigilance provides information that is useful in the analysis of the various 
causes of the untoward effects of blood transfusion. It provides reminders of known 
protective measures and helps to identify new ones. Haemovigilance has also 
helped to identify major technical, organizational and human errors. Table 1-10 
Summary of the types of clinical errorsTable 1-10 is a summary of the various 
types of clinical errors. 
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Table 1-10 Summary of the types of clinical errors 
Type of Error Number of 
cases  
in 2010 
Number of 
cases  
in 2011 
Wrong blood in tube (WBIT) 3 5 
Collection and administration 7 21 
Administration alone 8 8 
No information provided to the laboratory concerning the 
required group change. 
1 1 
Total 19 35 
Source: Serious Hazards of Transfusion, 2011, p.27 
In the first 18 months following the implementation of haemovigilance in France, 
seven fatalities related to the bacterial contamination of blood components were 
reported, while three fatalities related to ABO incompatibility were reported over the 
same period, leading to increased awareness of bacterial contamination as a major 
complication of blood transfusion (Engelfriet & Reesink, 2000, pp.59–62).  
1.7.2.2 Benign and caught errors 
The study of benign or caught errors in transfusion medicine could provide a rich 
database for improving the safety of the blood supply (Gambino & Mallon, 1991, 
p.14). The relationship between near misses and accidents has been compared to 
a pyramid or iceberg. Zapt and Reason (1994, p.427) indicated that error detection 
is the first step of error management. If an error is not detected, it cannot be 
managed. Errors that are not detected for a long time can have disastrous 
consequences.  
The goal of error management should be to increase error detection and the error 
response rate. High reporting rates indicate a high detection sensitivity level (DSL). 
Few reported events indicate a low DSL. A low DSL can be seen as an indicator of 
inadequate error detection and reporting. When the DSL is high, the severity level 
of the incidents should decrease over time as corrective actions are implemented 
(Kaplan, 2005, pp.1071–1081). In order to achieve a high DSL, an organisation 
must remove any impediments to reporting events. Confidential no-fault reporting is 
one of the best ways to encourage event reporting (Kaplan et al., 1998).  
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1.7.3. Causes of incidents in blood transfusion 
1.7.3.1 Technology 
The incorrect use or deficiencies in the technology used in blood transfusions 
continues to cause incidents (Tables 1.11 and 1.12). 
Table 1-11 Technological causes of blood transfusion errors. 
Error Wrong  
Blood 
component 
Non 
Irradiated 
component 
Antigen 
positive 
unit 
Non-
CMV 
unit 
Wrong 
blood 
group 
Others Total 
Failure to consult 
historical record 
2 0 3 0 1 0 6 
Historical record 
not linked, 
merged or 
identified 
1 2 3 0 0 0 6 
Ignored warning 
or missed flag 
3 3 2 3 0 1 12 
Failure to use 
flag or logic rule 
8 2 2 0 1 1 14 
Failure to update 
flag 
1 0 1 0 3 0 5 
Computer or 
related IT failure 
5 0 2 0 0 2 9 
Errors related to 
computer system 
2 2 0 0 0 0 4 
Error related to 
electronic blood 
management 
system  
4 0 0 0 0 7 11 
Incorrect results 
entered or 
accessed 
manually 
3 0 2 0 0 2 7 
Despite barriers created to prevented mistransfusion, few technological errors have been 
reported by SHOT. Common errors were due to software failure and hardware failure 
during blood product issuing. This reiterates the importance of human in the transfusion 
process.  
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Table 1-12 Patient identification tracking systems and errors prevented. 
Year Author System Number  
of units 
Errors  
prevented 
1991 Wenz BloodLoc 672 3 
2006 AuBuchon BloodLoc 86000 3 
1996 Mercuriali et al. BloodLoc 10995 4 
2000 Marconi et al. I-Trac 621 0 
2003 Turner, Casbard and Murphy I-Trac 51 0 
2006 Pagliaro and Rebulla I-Trac 18890 5 
2009 Davis et al. RFID - - 
Source: Serious Hazards of Transfusion, 2011, p.54 
Table 1-12 documented the errors prevented from blood tracking system, the figure 
might be low but this can been documented as good return of investment, litigation 
of accidents within health sectors can be very high. 
1.7.3.2 Compatibility testing 
Table 1-13 Special requirements incidents in the UK 
Type of special 
requirement 
Clinical 
cause of 
omission 
Laboratory 
omission 
Total 
Irradiation 69 22 91 
CMV negative 5 11 16 
CMV & Irradiation 5 6 11 
HLA matched 4 3 7 
HBS negative 1 5 6 
Pediatric methylene blue 0 1 1 
Phenotyped component 3 16 19 
Antigen negative 
component 
1 0 1 
Pediatric platelets 0 0 0 
TOTAL 88 64 152 
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Source: Serious Hazards of Transfusion, 2011, p.134 
1.7.3.3 Active and latent failures 
Reason (1990) identified two major categories of failures or error that occur in a 
complex system: active and latent. The distinction hinges on who initiated the 
failure. Latent failures are the delayed-action consequences of technical designs or 
organisational issues and decisions. They are often initiated at the upper levels of 
the organisation. Active failures are committed by people in direct contact with 
human/system interface. They are linked to human cognitive processes and 
associated behaviours. Error researchers have stressed the importance of 
examining both active and the underlying latent causes of system failures. 
Rasmussen (1987, p.23) distinguishes the following types of human behaviour 
underlying human error. 
 Skill-based behaviour: This refers to routine tasks requiring little or no 
conscious attention during execution. 
 Rule-based behaviour: This refers to familiar procedures applied to frequent 
decision-making situations. 
 Knowledge-based behaviour: This refers to problem-solving activities that 
happen when confronted with a new situation for which no readily available 
standard solution exists.  
Most health professional operate in a skill-based behavioural mode for routine 
tasks, from blood collection to the transfusion process (Kaplan et al., 1998). These 
highly skilled activities become routine and can be executed without any thought. 
Slips are unintended errors caused by either not doing part of the routine or being 
distracted by someone. Slips can be prevented by the redesign of equipment and 
procedures in ways that make it harder to make a slip. For example, feedback 
mechanisms can be designed into the process that alerts individuals. 
Rule-based behaviour involves recognising a situation and selecting the proper 
routine or protocol. Mistakes happen under two conditions, either by selecting the 
wrong rule for a given situation, or selecting the correct rule but carrying it out 
incorrectly. Such failures can occur when someone carries out a procedure that 
they are not trained or qualified to perform. Another example is inadequately 
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assessing the situation, for example failing to check the patient‟s identity before a 
transfusion (Kaplan et al., 1998). Routine violations often occur when procedures 
are changed and individuals continue to apply the old procedures. In some cases, 
rule-based failures can be prevented by redesigning the task to force a procedure 
to occur. An example would be a blood lock that prevents a transfusion starting 
until the patient‟s identity has been matched to the blood product. 
Knowledge-based behaviour involves solving unique problems or selecting a plan 
of action in a new or unfamiliar setting. It often occurs with new employees who do 
not have the knowledge to operate in a highly skilled mode and cannot draw upon 
experience to select the appropriate rule or protocol to carry out the appropriate 
task or solve a problem.  
This suggests that the expert and the novice are likely to make different types of 
errors. The expert is more likely to make a slip or an occasional rule-based error, 
while the novice is more susceptible to knowledge-based failures. This is a strong 
argument for assessing the performance of an individual when they move to a new 
job or assume new responsibilities. 
We can never eliminate human or active errors, but we can eliminate latent 
technical or organisational aspects that may set people up for an active failure 
(Reason, 1990). Reason refers to these as latent errors as organisational 
pathogens, which wait to combine with the right active human failure to have an 
adverse consequence. It is difficult to recognise a latent error or identify how it 
might manifest in the future as there are so many possible outcomes of technical 
and management decisions. However, since an event represents a fixed outcome, 
one is often able to identify the causes of latent errors by reasoning backward from 
the event. Once latent failures have been recognised, they can be diagnosed and 
corrected before they combine with an active error to produce an unwanted 
outcome. 
Technical aspects associated with latent failures include such things as equipment 
design, software and mobile and material facilities. Organisational aspects stem 
from normal management responsibilities, which include the structure of the 
organisation, planning and scheduling, forecasting, budgeting and allocating 
resources. 
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1.7.4  Incident reporting 
Although health care professionals share a common focus, which is taking personal 
responsibility for applying their skills to solve the patient‟s health problem (Curtain, 
1997), Perper (1994) noted that there is substantial underreporting of medical 
misadventures.  
This can be attributed to the tendency in the healthcare field to blame the individual 
or individuals associated with an active failure. This produces a climate where 
individuals are reluctant to report events in case there are adverse consequences. 
In addition, in a litigious environment it is easiest to blame the person involved. 
Reason (1990) pointed out that blaming individuals leads to ineffective 
countermeasures: disciplinary action, exhortations to be more careful, retraining 
and writing new procedures. Instead, error management efforts should be directed 
at learning how the system actually operates, as opposed to how to management 
thinks it is operating. Additionally, it is important to separate event reporting from 
employee assessment. Figure 1.4 highlights some factors that contribute to errors 
in healthcare delivery. 
 
Figure 1.4 Organisational accident model (adapted from Reason, 2001). 
 32 
 
Blood transfusion safety can be improved if errors (that are an indication of a weak 
system) can be identified before they result in an adverse outcome for a donor or 
patient. It is also important to avoid assigning blame when an error is identified, and 
to instead find the root causes of the error.  
1.7.4.1 Barriers and limitations to incident reporting 
Under-reporting of incidents is a widespread problem in the healthcare sector 
(Murff et al., 2003). The key factor highlighted by many authors is that the fear of 
reporting prevents the organisation from learning from the events and improving 
practices. Research in the healthcare and other industries has indicated that 
unjustified negative consequence have discouraged members of staff from 
reporting incidents. The non-punitive approach taken by the aviation industry has 
been a significant contributory factor to their impressive safety record in recent 
years (Vincent, Stanhope, & Crowley-Murphy, 1999). In 2004, the National Patient 
Safety Agency highlighted that the creation of strong safety culture in the 
healthcare system was necessary. They indicated that timely feedback and 
recommendations were essential to improved practice (National Patient Safety 
Agency, 2004). 
1.7.4.2 Overcoming the barriers to incident reporting 
High levels of reporting are a mark of high-reliability organisation. Research shows 
that Trusts in the UK with a high level of incident reporting are more likely to 
demonstrate a safety culture (National Patient Safety Agency, 2006). The 
involvement off all members of staff in the organisation can overcome under-
reporting. Staff members need to be provided with opportunities to reflect on 
practices in a multidisciplinary environment in order to become less fearful and give 
management an insight into the origins of incidents. More importantly, event 
analysis should be carried out with the members of staff who were involved in the 
incident, supported by a facilitator (Murff et al., 2003). Regulatory bodies and the 
health service have developed various reporting systems, although it is doubtful 
whether these reporting systems have in fact been utilised for organisational 
learning or to improve practice.  
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1.7.5  Hazards of  poor traceability compliance 
There is a lack of appreciation of the complexity of the traceability pathway. 
Traceability is poorly understood and inadequately controlled in many cases. The 
level of safety, efficacy and quality of blood products must be maintained and 
optimised on an on-going basis. The only real test of effectiveness tends to be in 
live situations when an adverse event has occurred and needs to be handled 
urgently. In such situations traceability has often found to be wanting with long 
delays in tracing products and identifying recipients (Ashford, 2006). 
Traceability is defined by three distinct elements. These are: the initial prescription 
of blood components, the distribution sheet stating the name of the recipient and 
the return of this sheet to the transfusion centre when the procedure is completed. 
The prescription, distribution and transfusion of blood components is a complex 
process within the transfusion chain, traceability compliance explores the quality 
management system of the process.   
1.7.5.1 The problems 
In 2007 the National Health Service issued the Health Service Circular „Better 
Blood Transfusion 2007‟, which outlined detailed actions to be taken by Trusts, 
NHS Blood and Transplant (NHSBT) and clinicians to improve transfusion practice 
(Department of Health, 1998a). In 2008 a national audit was carried out using an 
online survey. The survey showed that 60% of Trusts in the UK had implemented 
blood usage policies, 12% of Trusts had only assessed half of their staff and 13 
Trusts administered less than 10% of transfusions using technology.  
In 2001, an audit tool was developed for blood transfusion practice in a joint 
collaboration between the Royal Colleges and specialist blood transfusion 
societies. Fifty hospitals participated in the audit. The audit showed that 21% did 
not provide training to staff members in blood administration procedures and there 
was no wristband policy for patient identification at 11% of hospitals. While 80% of 
hospitals had compatibility reports attached to the patient‟s prescription chart only 
59% recorded the patient‟s pulse. The audit demonstrated considerable variations 
in standard procedures in relation to blood transfusion administration. However, it 
was difficult to draw valid conclusions as over half of hospitals failed to participate 
and patient selection was different at different hospitals. 
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In 2003, the National Patient Safety Agency commissioned a study of manual 
checking processes and the use of technologies in matching patients with blood 
(National Patient Safety Agency, 2004). The evidence revealed failures in the use 
of wristbands. An audit conducted at Guy‟s and St. Thomas Hospital identified that 
34% of patients were not wearing a wristband. 
Murphy and Kay (2004) looked at the extent of errors in many aspects of 
healthcare, including blood transfusion. Their review addressed issues of 
procedural errors and patient identification. The transfusion of blood to the wrong 
patient has been identified as the most important hazard. The risk of mistransfusion 
was found to be greater than the risk of transmission of HIV or HCV (Dzik, 2002, 
p.1190). The mistransfusion of blood products typically results from errors made 
during bedside checks prior to the transfusion (Sazama, 1990, p.583); this study 
estimated mistransfusion to occur at a rate of 1 in 12,000 units. Similar results were 
reported by Robillard, Chan and Kleimann (2004, p. 95) in Quebec. Moreover, they 
estimated that the incidence of mistransfusion was probably even higher due to the 
failure to recognise many errors. Another review by Pagliaro and Rebulla (2006, 
p.98), noted that errors in the blood transfusion chain seem to occur at a rate of 1 
in 1,000 events and the data probably underestimated the magnitude of failures, 
not least because only one-third of errors have clinically significant consequences 
(Steinbrook, 2002, p.1758).  
Finally, a Belgian study (Baele et al., 1994, p.117) uncovered numerous instances 
of mistransfusion that went unrecognised. When active tracking was introduced, 
they estimated that 1 in 400 units were mistransfused and the true frequency of 
some form of error in bedside blood administration was 30 times higher than rates 
reported using passive systems. 
1.7.5.2 Potential solutions 
Such studies have prompted the development of simple and effective 
methodologies to ensure correct patient identification in transfusion processes 
(Goodnough & Spence, 2003, p.161). The first positive donor-recipient 
identification study was described by Chambers et al. (1973, p.34). Since then, the 
main strategies that have been developed include the appointment of a transfusion 
safety officer, regular training, skills assessments, system re-engineering and the 
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introduction of standard operating procedures (Shulman, Saxena & Ramer, 1999, 
p.595).  
In addition to these organisational strategies, technology derived from industry and 
commerce has been incorporated into the blood transfusion chain. The ultimate 
purpose of these systems is to make the right and wrong actions easy and difficult 
respectively (Kohn, Corrigan & Donaldson, 1999).  
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Table 1-14 Literature review of traceability compliance 2001-2012. 
Author Method Blood 
components 
evaluated  
(red cells) 
Traceability 
compliance 
Not measured 
Ballard et al., 2002 Evaluation 486 units 84% Number of beds, 
training, specialties 
Turner, Casbard & 
Murphy, 2003 
Evaluation 51 units 100 Specialty, number of 
beds. 
Whitehead et al., 
2003 
Evaluation 1212 units 96%  
Kent & Sussex 
NHS, 2005 
Evaluation 250 units 10% Number of beds, 
training, specialties, 
fractionated products 
Dalton, Poncet and 
Rossini, 2005 
Evaluation 1500 units 100% Number of beds, 
training, specialties, 
fractionated products 
Dzik, 2006 Review 2000 units 75% Number of beds, 
training, specialties. 
Fractionated products 
not traced. 
Davies et al., 2006 Observation 
evaluation 
80 units 60% Number of beds, 
training, specialties. 
Fractionated products 
not traced 
Pasqualoepaolo, 
2008 
Evaluation 235 units 100% Number of beds, 
training, specialties. 
Fractionated products 
not traced 
Murphy, 2008 Audit 153 units 92% Number of beds, 
training, specialties, 
fractionated products 
Bennardello et al., 
2009 
Evaluation 7282 units 100% Number of beds, 
training, specialties 
Davis et al., 2009 Evaluation   Blood product 
Mathur, 2006 Evaluation 311 units 64% Specialties, training, 
number of beds 
The aim of the study by Ballard et al. (2002, p.127) was to establish whether a 
patient had received a particular unit recorded on the blood transfusion computer 
system. They reported that 486 blood products were issued over a two-month 
period. Of these, 409 units (84%) could be verified against patient notes, but 77 
units could not. These results are slightly lower than a national audit which found 
92% compatibility (Murphy, Lowe & Pearson, 2001). The study was not large; a 
random sample of 5% of patients transfused February–March 2001. It also 
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highlighted inconsistencies in documentation. Although the blood bank kept records 
of the issue of blood components, they did not know the ultimate destination of the 
blood, unless it was returned to them. The only proof that a specific unit had been 
transfused to a patient lay in the patient‟s notes. This study did not identify or 
describe the problem across different medical specialities. 
Turner, Casbard and Murphy (2003) carried out a retrospective study. A total of 51 
blood units were audited before and after the introduction of barcode patient 
identification. The baseline data showed that only 14% of patients were asked to 
verbally identify themselves before the administration of blood. Twelve per cent of 
patients were not wearing their identification wristband when identification checks 
were carried out. Non-compliance was shown to be particularly related to poor 
checking of special blood requirements; proper procedures were followed in only 
41% of cases. Furthermore, the study highlighted that there was no audible 
communication between staff members and the patient in relation to special blood 
requirements. After the introduction of barcode technology patients were asked to 
state their surname and forename and 96% of patients with special requirements 
had these matched to information on the blood bag. However, the barcode 
technology did not guarantee that all the necessary steps had been carried out as 
individuals could indicate that they had carried out checks when in fact they had 
not. This study also did not identify the particular medical area. 
Whitehead et al. (2003) conducted a survey of 500 sets of patient notes. A total of 
1,212 blood components were issued and 47 labels were found to be missing. 
Nursing staff in the clinical area were asked to assess a new system that used 
peel-off labels to be stuck in patient notes. Almost all respondents preferred the 
new system and found the labels easy to use. Other initiatives to improve the 
safety of the blood transfusion process included an improved blood collection 
protocol and staff training by a transfusion nurse.  
Davies et al. (2006) carried out an extended evaluation of an electronic blood 
collection system based on barcode technology. Practices were evaluated before 
and after its introduction in cardiac surgery. The baseline audit showed that patient 
documentation was brought to the refrigerator in 84%, 40% and 10% of collections 
from the main blood bank, theatre and the cardiac rehabilitation unit refrigerators 
respectively. Following the introduction of the electronic process, this increased to 
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95%, 90% and 100% respectively. The study estimated that there were 23 steps in 
the collection of blood before the implementation of the electronic process; this was 
reduced to nine.  
The baseline audit demonstrated that there was very poor documentation of the 
date and time of transfusion and the number of units transfused. Observation of 
practices before implementation of the new procedures revealed that almost all the 
key steps in the transfusion process were not carried out correctly. The design of 
the electronic process highlighted the complexity of the transfusion process, which 
was identified as a problem. Another problem was improved training to avoid over-
reliance on the technology for the patient identification. A further weakness was 
that nursing staff were not required to enter any observations during and after the 
transfusion.  
The study highlighted that the main reason for introducing electronic checking was 
that checking procedures were not being carried out correctly. However, the 
authors pointed out that total reliance the electronic system was also undesirable 
as the system was likely to fail from time to time. The study concluded that 
technology should not be used to take over thinking and that it was vital not to 
underestimate the role of education, training, and continued support.  
A study by Davies et al. (2006, p.361) observed that traceability compliance was 
poor in some clinical areas because of the complexity of the transfusion chain and 
procedures. There were many steps in the requesting, matching, delivering and 
transfusing of blood products that involved a number of different departments and 
staff of different grades.  
A pilot study at San Raffaele Hospital in Milan by Dalton, Poncet and Rossini 
(2005) used radiofrequency identification (RFID). Blood donors were given a RFID 
wristband and a label was placed on their donor unit at the time of donation. Later, 
at the time of transfusion, the data on the wristband and the blood unit were 
compared at the bedside using a handheld RFID reader. The reader communicated 
with the hospital computer via a hospital-wide wireless network. Users of this 
device reported that they were 27% more productive and no errors were observed 
during the pilot. Although it was difficult to measure the impact of the technology as 
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only data estimates were collected prior to the study, 70% of staff commented that 
the system had dramatically reduced their fear of making errors.  
Another pilot study at Maidstone Hospital in Kent used a questionnaire to evaluate 
a new labelling system. Seventy-nine per cent of respondents agreed that the 
labels were easy to use, although the poor response rate made it impossible to 
draw robust statistical conclusions from the analysis (NPSA,2006). 
Salmi, Azanowsky and Perez (1997, pp. 964–974) highlighted that data gathered 
from alert systems must be carefully interpreted to minimise bias. While Battle et al. 
(1998) emphasized that the characteristics of a good vigilance system should 
include no-fault reporting. They recommended that the donation number for blood 
and blood components and batch products for pooled blood products should be 
specifically recorded on the transfusion record. They also recommended the 
establishment of national documentation standards. 
Other solutions have been proposed to the problem of ensuring that the correct 
blood unit is given to the patient. They include paper-based systems (Lau et al., 
2000), mechanical systems (AuBuchon & Littenberg, 1996) and electronic systems 
(Norfolk, 2000). Dzik (2003) discussed technological approaches. The study 
highlighted that reductions in transfusion-related, knowledge-based errors 
depended on increased knowledge, more informed decision making and enhanced 
feedback. It also noted that reductions in slip errors was a problem ideally suited to 
machine-readable identification systems. Consolidated methodologies include 
biometric technologies, such as fingerprint identification, facial and vocal 
recognition (Ashbourn, 2004). Some of these technologies are not readily 
applicable to the field of medicine and surgery.  
1.7.5.3 Conclusions 
Although considerable effort has been devoted to improving traceability compliance 
following the introduction of national regulations,guidelines and mechanical barriers 
to prevent mistransfusion Davies et al. (2006),  the literature review did not reveal 
any clear procedure for achieving it. The studies described in the previous sections 
suggest that the traceability of blood products is a problem in all hospital 
transfusion laboratories. Dzik (2006) and Murphy, Stearn and Dzik (2004) suggest 
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that training and education might improve matters. Bennardello et al. (2009) and 
Pagliaro and Turdo (2008) also agreed that mechanical intervention may help.  
However, none of these approaches attempted to assess the impact of ward size, 
speciality, training, traceability methods or volume of transfusion. There were 
considerable variations in the population and sampling criteria used in the various 
studies, and weaknesses in the audit tools. The articles reviewed also varied in 
quality and relevance. Most studies did not describe how fractionated products 
were traced from the donor to the recipient and none of them evaluated the 
variables that may affect traceability compliance, such as blood product usage by 
different specialities. 
The design of some the studies was not explained which may have affected the 
results obtained. Other studies highlighted the problem before the introduction of 
the new model or simply explained improvements in traceability compliance. 
(Murphy and colleagues 2003), However, identified in their study tha the barcode 
technology did not guarantee that all the necessary steps had been carried out and 
the system can be overridden.  
These findings justified the need of further investigation into why traceability 
compliance was poor within the Trust and why some wards were more compliant 
than others and the associated risk factors. While patients may be the victims of 
human errors, members of staff can be the targets and casualties of systems that 
are highly error-prone this will mostly contradict the research conducted by 
(NPSA,2006) that demonstrated that Trusts in the UK with a high level of incident 
reporting are more likely to demonstrate a safety culture (National Patient Safety 
Agency, 2006).  
 
1.8 Proposed programme of research 
The literature review had revealed weakness in traceability procedures in the 
healthcare sector and looked at some reasons why compliance is poor is some 
areas. In some Trusts, considerable effort has been devoted to improving training, 
redesigning electronic systems and proper patient identification before and after 
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transfusion. However, none of these approaches have fully addressed the 
complexity of the transfusion chain which involves different specialities and staff. 
Mandatory requirements introduced by European legislation, clinical governance 
and patient safety concerns made this project necessary. There is a need for 
further exploration and better understanding of the issues surrounding traceability. I 
have some identified some that are realistic within the scope of this study. The 
findings from this study will provide new knowledge and understanding of these 
challenging problems. 
1.8.1 Research aim and objectives 
The overall aims of the project were to establish why traceability compliance was 
poor in the Homerton University NHS Trust, to implement changes to improve 
traceability compliance and to ensure that hospital wards complied with traceability 
procedures. Compliance was also expected to identify blood distribution and 
administration within the Trust.  
1.8.1.1 Objectives 
The study‟s objectives were as follows: 
i. To undertake a six year cohort study to identify the risk factors of 
traceability compliance for blood products within all wards of the Homerton 
University Hospital NHS Trust and identify the processes that lead to poor 
compliance.  
ii. To select an appropriate traceability model and labelling procedure for 
blood products within the Homerton University Hospital NHS Trust.  
iii. To evaluate the subsequent intervention. 
iv. To evaluate impact and direct cost and saving blood products. 
v. To examine the transferability of this evaluation and reflect on the impact on 
practice. 
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Cross sectional study
detailed audit of ward compliance
Questionnaires sent to ward managers 
– training, knowledge, responsibilities, 
opinion, training, blood collection and 
administratiom
Risk factors for poor compliance 
within the Trust
Select an appropriate traceability 
model
To implement the new traceability 
model
The impact of traceability 
compliance within the Trust
Rigourous review of studies on the 
effectiveness of blood tracking 
system
Cross sectional survey of blood 
traceability mechanism in hospital 
Trust within North East London region
Cross sectional study
Detailed audit of ward compliance, Airtube 
system, business case for medical laboratory 
assistant & Transfusion Nurse specialist
Implementation and evaluation of a blood products 
traceability procedure in a District General Hospital 
Direct cost saving  of wastage, 100% full 
compliance maintained with a robust process 
in place with improved communication 
barrier.
To examine the tranferability and 
reflect on the impact on practice
                        Research achievement
 100% traceability compliance
 Transfusion specialist and Medical Lab Assistant
 Development of competency assessment
 Redesign of  information technology
 Air-tube system installation  extended to all wards
 Provision of clinical supervision
 Development of clinical guidelines within Trust and
annual competency  of staff is currently at 95%
 
Fig. 1.5  Flow diagram identifying elements of the study. 
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2 Traceability compliance assessment 
(Method 1) 
This chapter describes the situation in Homerton University Hospital NHS Trust 
with respect to compliance with traceability requirements for blood products at the 
beginning of the study. It also identifies the processes associated with poor levels 
of compliance. The information gathered and the analyses carried out in this phase 
of the project provided the basis for the development of the modified traceability 
system described in Chapter 4.  
This stage of the project took place from 2005-08. At this time the Trust had 
implemented a paper-based traceability method and paperwork was transported by 
porters (referred to as Method 1).  
Compliance was evaluated in two phases. In phase 1, traceability compliance was 
calculated as the number of blood units successfully traced as a percentage of all 
units issued from the blood stock fridge. The second phase looked at the potential 
causes of poor compliance. Data was collected on the communication of the 
traceability procedure to ward managers, access to training and the communication 
of audit results to the wards. A statistical analysis of the data made it possible to 
estimate the risk factors that influenced ward compliance rates within the Trust See 
Table 2-1. Furthermore, a structured observation tool evaluated the compliance of 
a sample of ward staff with the following procedures: 
i. Blood collection at the blood stock fridge. 
ii. Ward bedside checking procedures.  
The Trust is a  500 beds hospital, medium size teaching hospital and offers many 
services that require high amounts of blood transfusion in the Accident and 
Emergency (A/E), Special Care Baby Unit (SCBU), Medical Day Unit (MDU), 
Delivery Suite (DEL) and Acute Care Unit (ACU). Biomedical scientists routinely 
carry out pre-transfusion testing prior to the issue of blood products and 
transfusions are subsequently carried out on the wards or theatre by nursing staff. 
Since 2005, an average of 6,000 red blood cells have been transfused annually. 
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Transfusion compatibility labels had been modified by the Hospital Transfusion 
Team prior to the implementation of the European Union Directive (Blood Safety 
and Quality Regulation, 2005) to include the date, time of transfusion and 
signatures of nurses. Following each transfusion the ward nurse was responsible 
for removing the empty blood bag and completing the information on the label. 
Finally, the completed labels were placed in a Perspex box marked “returned 
transfused tags”. 
Hospital porters visited the wards on a daily basis to collect and return labels to the 
laboratory. Data from the ward (date and time of transfusion) was entered into the 
blood transfusion computer system by the medical laboratory assistant. Data was 
compiled on a monthly basis and sent to the respective wards. 
2.1.1 Phase one: Quantitative assessment of traceability 
compliance 
2.1.1.1 Ethics 
The hospital‟s local Research and Ethics division confirmed that the project did not 
require ethical approval by a NHS Research Ethics Committee or the Trust‟s 
research and development department; however approval was needed from the 
Trust‟s clinical governance committee. Appendix 2 is a copy of the approval 
document.  
2.1.1.2 Method 
Data about patient blood transfusions was gathered and reviewed after every 
transfusion and the subsequent discharge of the patient. The data was extracted 
from the blood transfusion information system and consisted of the final destination 
of all transfused blood that could be traced and all the blood units assumed to have 
been transfused (where tags were missing or labels had been destroyed). The final 
traceability compliance was calculated as the number of units successfully traced 
as a percentage of the total units issued. 
All wards with more than two transfusion episodes per week were eligible for 
inclusion in the study. Others, with less than two transfusion episodes per week 
were excluded because their patients would eventually be transferred to other 
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wards. Participation in the study was voluntary. I extracted data for each ward from 
the blood transfusion laboratory information system on a monthly basis.  
Compliance was calculated as the total number of units where the final destination 
could be traced (T) divided by the total of number of blood units issued (I) 
expressed as percentage.  
I implemented a database to record all the units transfused and calculated the 
percentage compliance using the Statistical Package for Social Sciences (SPSS, 
2010) software.  
Descriptive statistics were used to determined the mean and standard deviation of 
the annual compliance rate for each ward. Variance analysis determined whether 
the frequency of transfusion was a predictor of compliance at a ward level. Wards 
were categorized into three groups according to blood usage. Those that 
consumed less than 500 units were grouped as low users, medium users 
transfused 500-1200 blood units and those that transfused over 1201 blood units 
were grouped as high users. 
2.1.1.3 Results  
The compliance data was normally distributed from 2005-08, the average 
traceability compliance ranged from 50 – 90% (see Table 2-1 below). The overall 
mean compliance for the entire period for all wards was 72% with a standard 
deviation of 10.4. 
 
2.1.1.1 Results 
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Table 2-1 Mean ward traceability compliance.  
Ward Number of blood 
units transfused  
2005-08 
Mean compliance  
2005–2008 (%) 
CCU 244 50 
TEMP 284 60 
TUR 307 60 
OT1 585 60 
HAL 1156 60 
COX 276 61 
DEL 1200 64 
DEFOE 262 69 
MAU 284 70 
ST JOE 376 70 
TAUD 310 71 
PRI 985 72 
ACU 2268 72 
ASKE 563 74 
LAMB 447 75 
EC 1414 75 
ITU 1728 75 
AE 3051 76 
LLOYD 697 79 
ANC 2501 83 
DSU 262 84 
HAE 420 87 
SCBU 4962 90 
MDU 3597 90 
An analysis by year showed that although there was a steady increase (50-80%) in 
overall percentage compliance from 2005-2007, in 2008 it fell to 65%. The overall 
average traceability compliance for all wards for 2005-2008 was 69% with a 
standard deviation of 13.5. The transfusion department approach after the visitation 
of MHRA in 2006 was to target non-compliant ward and personnel through incident 
reporting, this led to a revolt by some clinicians who definitely opted out and labels 
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were incomplete labels were discarded in wards bins but retrieved for audit, this 
might have suggest a poor compliance in 2008 as shown in  (see Table 2-2). 
Table 2-2 Compliance as percentage of units issued for all wards 2005-08.  
Year Compliance  
as a % of all units issued  
n = 24 
Standard  
deviation  
 
2005 49.6 (17.7) 
2006 65.9 (15.4) 
2007 82.3 (9.9) 
2008 64.8 (14.4) 
An interesting finding was that as the number of units transfused increased there 
was a corresponding increase in traceability compliance (Figure 2.1).  
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Figure 2.1 Correlation between traceability compliance and units transfused 
This relationship was analysed in more detail and wards were divided into low, 
medium and high usage groups. Variance analysis showed that there was a 
significant difference in the compliance of the three groups (F = 14.52; p < 0.001) 
(Figure 2.2) and this relationship was maintained even when each year was 
evaluated individually (Table 2-3).  
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Figure 2.2 Percentage compliance for usage groups. Chi-square = 297; p < 0.001 
Table 2-3 Traceability compliance for all wards 2005-2008. 
 Wards  F p-value 
2005 All wards 6.36 0.006 
2006 All wards 13.76 < 0.001 
2007 All wards 9.51 < 0.001 
2008 All wards 14.20 < 0.001 
In the period 2005-2008, low usage groups had an average compliance of 68.5%. 
Medium usage groups had an average compliance of 73.8 and high usage groups 
had an average compliance of 80.2% (see Table 2-4). Moreover, the low usage 
group had a significant lower compliance rate than the medium and high usage 
groups (p < 0.001) using the independent T test.   
Table 2-4 Traceability compliance for usage groups 2005-2008 
Usage group Compliance Confidence interval 
Low 68.5% 95% CI = 65.1 to 68.6  
Medium 73.8% 95% CI = 72.4 to 75.2 
High 80.2% 95% CI = 79.7 to 80.7 
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2.1.2  Phase two: Survey of ward managers 
The study was approved by the clinical governance committee of the Homerton 
University Hospital NHS Trust. Emphasis was placed on voluntary informed 
consent. The questionnaire was anonymous and any personal information that 
could identify the respondent was kept to a minimum. 
2.1.2.1 Method 
A quantitative method was used because the frequency of occurrence was used to 
answer my research questions and this approach ensured that I was able to collect 
data and interpret comparatively. A major strength of using this method is that it 
minimise bias in gathering, communicating information and makes it possible to 
obtain precise information. Numbers are less vague than words. Qualitative 
findings often are the basis for formulating hypothesis. Qualitative studies help 
shape perceptions of a problem or situation and were not used. 
The questionnaire was initially piloted to ensure that respondents could understand 
the questions and the response format was suitable. It was divided into sections 
that covered various aspects of the transfusion chain, including user satisfaction 
and performance related to traceability compliance. The objective of the survey 
was to gather more information related to the following research areas: 
 Training related to blood product collection and administration. 
 Knowledge of traceability procedures. 
 How traceability compliance can be improved within the Trust. 
 Laboratory staff professionalism. 
 Ward staff responsibilities related to compliance. 
 Ward staff opinion on traceability. 
 General considerations. 
A postal questionnaire was used as this mitigates the effect of social acquiescence 
particularly as some questions could have been considered sensitive (e.g. ward 
staff compliance with Trust policy). A self-addressed envelope was enclosed for 
return of the questionnaire. A reminder letter was sent approximately a month later 
to encourage replies from non-responders. The initial response was not satisfactory 
with a total of 10 out of 36 (28%) returns. Further telephone calls were made to 
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ward managers and a further 20 questionnaires were returned with a final response 
rate of 30 out of 36 (83%). During the data analysis, the outstanding non-
responders returned their questionnaires, which were included in the final analysis 
shown in Table 2-5. 
A Likert-style rating scale was used, which asked the respondent to rate how 
strongly they agreed or disagreed with a statement or series of statements. The 
data collected was verified by a departmental biomedical scientist to ensure 
accurate data entry, eliminate errors and identify missing values. 
The data collected from the questionnaire was entered into a spreadsheet and 
analysed using the SPSS statistical package (SPSS, 2010). All data was screened 
to ensure that it did not violate the assumptions of non-parametric testing. 
Descriptive statistics for each item were calculated.  
The Kruskal-Wallis test is a non-parametric test used to compare more than two 
independent groups. This test was used to compare the compliance rate between 
different groups (e.g. specialities). Spearman‟s rank correlation coefficient was 
used to analyse the strength of the relationship between continuous variables and 
traceability compliance and the Mann-Whitney U test was used to compare 
differences between two independent groups when the dependent variable was 
either (a) ordinal or (b) interval but not normally distributed.  
2.1.2.2  Results  
The results of the questionnaire sent to ward managers  are shown in table 2-5 and 
2.6 below. 
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Table 2-5 Ward demographics 
Specialty n = 36  Frequency (%) 
AE 1 (3) 
Medical 19 (53) 
Surgical 5 (14) 
SCBU 1 (3) 
Obstetrics 7 (19) 
Geriatric 3 (8) 
Total 36 (100) 
Number of beds on the ward 
1-10 12 (32) 
11-20 15 (43) 
21-30 5 (14) 
31-40 4 (11) 
Total 36 (100) 
Schedule of transfusion 
Day and night 21 (59) 
Day 4 (11) 
Not applicable 11 (30) 
Total 36 (100) 
Trainer on the wards 
No trainer 32 (89) 
Trainer 4 (11) 
Total 36 (100) 
Method of sending of transfused labels 
Single sending procure 24 (67) 
Multiple sending procedure 12 (33) 
Total 36 (100) 
Staff training within the Trust % 
0-25 1 (3) 
26-50 7 (19) 
51-75 6 (17) 
76-100 22 (61) 
Total 36 (100) 
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Table 2-6 Ward managers’ assessment of traceability compliance. 
Traceability compliance training (n = 36) Agree Disagree No 
response 
All my staff have been trained 27 (75%) 1 (3%) 8 (22%) 
I have enough training materials 27 (75%) 1 (3%) 8 (22%) 
I need more resources for training 27 (75%) 2 (6%) 7 (19%) 
Some staff were trained on the job 28 (78%) 1 (3%) 7 (19%) 
E-learning will help me do my job 5 (14%) 27 (78%) 3 (8%) 
Locum staff can collect blood products 3 (8%) 31 (86%) 2 (6%) 
Knowledge 
I understand the importance of traceability 
compliance 
30 (83%) 2 (6%) 4 (11%) 
I understand the importance of returning labels 31 (86%) 2 (6%) 3 (8%) 
Labels are returned immediately after transfusion 30 (83%) 3 (8%) 3 (8%) 
We are given monthly feedback about ward 
compliance 
17 (48%) 16 (44%) 3 (8%) 
Improving traceability compliance 
Competency assessment can improve traceability 
compliance 
26 (76%) 6 (16%) 3 (8%) 
Methods of returning labels can be improved 20 (56%) 13 (36%) 3 (8%) 
Too busy to send labels back to the laboratory 21 (59%) 12 (33%) 3 (8%) 
Attitude and perceptions to lab staff 
I get prompt responses from the laboratory 32 (89%) 3 (8%) 1 (3%) 
We are informed about missing labels 28 (78%) 5 (14%) 3 (8%) 
We are given feedback about traceability 
compliance 
20 (56%) 13 (36%) 3 (8%) 
Staff courtesy and professionalism is good at all 
times 
28 (78%) 5 (14%) 3 (8%) 
Response time in answering telephone calls is 
acceptable 
32 (89%) 3 (8%) 1 (3%) 
Ward staff responsibilities 
The ward staff are responsible for returning 
compatibility labels 
32 (89%) 2 (5%) 2 (6%) 
The porters return compatibility labels 12 (33%) 20 (56%) 4 (11%) 
There are clear procedures for returning labels 26 (72%) 7 (19%) 3 (8%) 
Labels are left on the transfusion bag and sent to 
the lab 
11 (31%) 22 (61%) 3 (8%) 
Transfused patients 
Patients are constantly transferred to a different 
ward 
18 (50%) 15 (42%) 3 (8%) 
Transfusion rarely takes place on the ward 19 (53%) 13 (36%) 4 (11%) 
Wrong ward details on the labels and forms are 
common 
14 (39%) 17 (48%) 5 (13%) 
Ward staff attitude 
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Ward staff know what to do if compatibility labels 
are misplaced 
26 (72%) 7 (20%) 3 (8%) 
Ward staff are regularly informed about 
traceability compliance  
13 (36%) 20 (56%) 3 (8%) 
Ward staff are encouraged to report lost or 
damaged labels  
19 (53%) 14 (39%) 3 (8%) 
The data was not normally distributed; a Kruskal-Wallis test was used to compare 
the relationship between average compliance and the various specialties. The 
results showed that there were no significant differences in compliance rates 
between specialties (p > 0.05; median 0.21). These outcomes suggested that 
traceability compliance was not associated with speciality. However, as there were 
only six specialty groups the study may not have been in a position to detect a 
significant difference. 
The Kruskal-Wallis test also was used to compare the relationship between 
number of beds and average traceability compliance. The number of beds on the 
wards did not influence compliance rates (p = 0.70; median 0.49). 
The Mann-Whitney U test was used to compare the relationship between average 
compliance and the presence or absence of a trainer on the ward. A statistically 
significant difference was found; average traceability compliance was better with a 
trainer on the ward (p = 0.03; median 0.16). Sixty-one per cent of respondents 
reported that 76-100% of their staff had been trained within the past year. It was 
evident that as the number of trained staff increased, compliance improved 
across all wards. Spearman‟s rank correlation coefficient showed a strong 
correlation between the proportion of trained staff and traceability compliance (r = 
0.59; p = 0.002).  
Another statistically significant difference was found between timing of 
transfusions and average traceability compliance (p = 0.04; median 0.59). 
Traceability compliance was better during the day than at night. However, the 
compliance rate was not associated with the method of sending labels (p = 0.14; 
median 0.40).  
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Table 2-6 shows that not all respondents had a clear understanding of the 
procedures for sending transfused blood labels back to the laboratory. Nineteen 
per cent of respondent did not agree that there were clear procedures for returning 
labels, although 56% of respondents agreed that they were informed about monthly 
traceability compliance. It was also evident that some respondents did not think 
that they should report damaged or destroyed labels. 
The transfer of patients between wards could be considered another risk factor 
for traceability compliance. Fifty per cent of respondents agreed. 
2.1.3 Phase two: Direct observation 
Direct observation was used to supplement the information obtained through the 
questionnaire.  
2.1.3.1 Method 
A structured observation checklist was designed to evaluate blood collection and 
bedside checking procedures at the Trust. The checklist highlighted relevant 
information about how blood products should be collected and checked at the issue 
fridge and patient‟s bedside respectively. The checklist covered the procedures and 
standards issued by National Patient Safety Agency and SHOT, and British 
Committee for Standard in Hematology guidelines for blood collection. It also 
included the procedures displayed at the blood collection point and the bedside 
checking procedure on the ward.  
The drawback of observational data activities is that they are time-consuming and 
the volume of data generated is immense. Therefore the sample size was kept 
small. One of the threats to the validity and reliability of data collected through 
observation is that of the observation effect. Another is time error. It is essential 
that the time at which the observation is conducted does not provide data that is 
atypical of the total period of the study. 
I gave careful consideration to the composition of the sample. Because of 
variations in blood collection, shift patterns, time availability and other practical 
difficulties, I was the only researcher involved in data collection. Random sampling 
would have been preferable but this was impossible because of the transfusion 
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patterns in the Trust. An average of six transfusions takes place on a normal day 
and fewer than two during the night.  
Due to a lack of access to the target population, a sample of 58 different 
transfusion episodes was observed. This represented 10% of the average monthly 
transfusions on the wards. The study was entirely voluntary and personal 
information that could be used to identify participants was kept to a minimum. All 
wards involved in the collection and administration of blood products with more 
than two transfusion episodes per week were included. Participants included staff 
members who collected and administered blood products on the ward. The 
anonymity of the staff members observed was protected. 
2.1.3.2 Results 
Data from the checklist was entered on into a spreadsheet and analysed using 
SPSS software (SPSS, 2010). The data generated by the observation was coded 
to enable a numerical analysis. Coding took the form of: 1 = compliant, 2 = non-
compliant and 3 = non-applicable. 
Table 2-7 Observed compliance by ward staff  
Question Compliant Non-compliant 
Blood collection procedure 
Patient‟s prescription chart brought to the collection point 56 (97%) 2(3%) 
Blood pack ID checked against report and labels 57 (97%) 1 (3.0%) 
Procedure for blood collection followed as stated by the 
standard operating procedures 
54 (83%) 4 (17%) 
Transport box used to collect unit 48 (82%) 10 (18%) 
Bedside checking procedure 
Patient‟s notes brought to the bedside 50 (86%) 8 (14%) 
Patient‟s ID checked against the form 48 (83%) 10 (17%) 
Blood pack ID checked against the patient‟s ID wristband 50 (86%) 8 (14%) 
Checking procedures carried out by two qualified nurses 56 (97%) 2 (3%) 
Patient confirms all details 56 (97%) 2 (3%) 
All identification correct 56 (97%) 2 (3%) 
Starting time of transaction recorded 54 (93%) 4 (7%) 
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Overall, the results obtained from the blood collection point and bedside check 
suggested that most of the time ward staff did comply with checking procedures at 
the blood collection point and the patient‟s bedside. However, full compliance was 
not achieved at the blood collection point. Seven per cent of observed participants 
did not bring the prescription sheet for checking at the blood collection point, 
leading to the possibility of collecting the wrong blood. The transport box was not 
used by 18% of participants for blood collection, which increases the incidence of 
storage and wastage error. There was also non-compliance with the bedside 
checking procedure by ward staff. Seventeen per cent of observed staff did not 
check the patient‟s identification against the blood transfusion request form. The 
patient‟s notes were not used in the bedside checking procedure by 14% of 
observed staff and the blood pack was not checked against the form by another 
14%.  
My results was comparable to the National Comparative Audit of blood collection 
conducted in 2009, which identified that 3.9% of staff did not bring documented 
patient identification during blood collection and 5.3% did not check documentation 
against the blood bag collected.  
2.1.4 Discussion 
The peak percentage traceability compliance of 82% was obtained in 2007. This 
was followed by a drop to 65% in 2008. This led to the conclusion that the existing 
approach to resolving poor compliance (reporting non-compliance using the Trust‟s 
incident reporting mechanism and targeting staff) did not resolve the issue. 
Moreover, reviewing the volume of incidents from wards was not sustainable. The 
lowest traceability compliance was 50%, in 2005. The overall average traceability 
compliance from 2005-2008 was 69%. This shows that there was some 
improvement but it was not good enough. The results justified the need for 
establishing an enhanced system of transfusion practice and a well-structured 
change management programme which was not given a full attention during the 
study. The presence and absence of a trainer on the ward had a positive impact on 
traceability compliance within the Trust, there was a significant difference, 
It was encouraging to note that most of the procedures in the observation 
checklists were being adhered to. It was also encouraging to note that there was a 
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high awareness of error reporting in the Trust. Safety in blood transfusion is 
enhanced if errors can be identified before they result into an adverse outcome for 
a donor or patient (AuBuchon & Litternberg, 1996). Sellu et al., (2012) also 
highlighted in their study that simulation training is one way in which staff within the 
blood transfusion chain can be assessed effectively. This form of training has been 
used in the aviation industry to decrease system failures and individual errors and 
to introduce this method in the transfusion process is not easy as thought. 
2.1.4.1 Blood usage levels and compliance 
The study demonstrated a positive, significant correlation between the number of 
units transfused and user compliance. Medium and high usage groups had higher 
average traceability compliance than low usage groups throughout the years that 
were investigated (2005-2008). High and medium usage groups did not have 
significantly different means. 
2.1.4.2 Staff training 
Eighty-nine per cent of respondents reported that they did not have a trained 
transfusion trainer or nurse on their ward, while 11% said they had such a 
specialist in-house. When there was no in-house trainer, the results showed that 
training was still given importance, even if a trainer was not available. This outcome 
suggested that training is a key element in the Trust.  
The majority of the wards were aware of the importance of staff training, and this 
was highlighted by Murphy et al. (2004) who found that training and education may 
improve traceability compliance. The employment of a ward trainer is not as critical 
as the provision of other modes or means of training. However, the provision of 
training is significantly and positively correlated with traceability compliance.  
2.1.4.3 Blood labelling 
The results of the survey suggested that staff members agreed on the importance 
of blood labels. Moreover, survey participants strongly agreed that labels should be 
returned immediately after transfusion and they understood the importance of 
traceability compliance. It was encouraging to note that all the statements in the 
survey related to this area were evaluated positively by respondents. 
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2.1.4.4 Blood and patient identification 
Out of all the behaviours that were observed using the bedside point observation 
checklist, the ones which were least observed were the patient's identity being 
checked against forms and labels and the blood pack identification being checked 
against reports and labels. Of the blood collection point checklist behaviours that 
were observed, the ones that were least respected were using the right transport 
box, patient identification being brought to the collection point and patient 
identification being checked against reports and labels. While staff members take 
their responsibilities in the transfusion process seriously, acknowledge the 
importance of training and skills assessment and generally follow working 
procedures there may be a need for a more permanent, technological intervention 
to increase traceability compliance.  
This is consistent with the results from Novis et al. (2003) who assessed the 
frequency with which the basic elements of bedside checking procedures were 
performed, including patient identification, blood compatibility identification and 
expiry date information. Their study revealed a failure to match wristband 
identification with the compatibility label in 25% of blood transfusions. The 
outcomes of the current study showed persistent difficulties in observing these 
patient identification protocols.  
Errors in the blood transfusion process frequently relate to patient identification, 
blood units and its components. These erroneous slips can be reduced with the 
help of different techniques (Linden et al., 2000). In the case of the current study, it 
was found that majority of the wards still employed a paper-based tracking system. 
There are many alternative technological approaches that may help to improve 
traceability compliance, such as mechanical barriers, barcodes, computerisation, 
automatic interface systems, portable computers and radiofrequency devices, and 
automated blood stores.  
2.1.4.5 Feedback mechanisms 
Slips are unintended errors caused by either not doing part of the routine or being 
distracted by someone. Slips can be avoided by the redesign of equipment and 
procedures in ways that make it more difficult to make a slip. For instance, a 
feedback mechanism can be designed into the IT system that alerts the individual 
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when a slip is made i.e. alert from system to request label sent back and time and 
question operator if odd decisions were made. This is one approach that could be 
taken by the Trust to enhance traceability compliance. 
2.1.4.6 Technology 
Tracking blood samples using RFID technology has been cited in a number of 
studies looking at blood products and may be considered by the Trust. However, 
carrier and reader consistency and reliability are problems. A detailed evaluation is 
necessary to establish the limits of such advanced technology. 
2.1.4.7 Patient transfer periods 
The results indicated that the patient transfer period was significantly and positively 
correlated with ward compliance. The patient transfer period was measured by the 
number of patients transferred to other wards. Transfers happen regularly on wards 
and it is common to find the wrong ward indicated on the compatibility form and 
label.  
The transfer period may be classified as an active failure since it is the health 
professional who decides it. A significant and positive correlation with traceability 
compliance indicates that as transfers to different wards become more frequent 
and the identification of the wrong ward on compatibility forms and labels 
increases, the likelihood of compliance increases correspondingly. Possibly, the 
identification of such errors causes more stringent enforcement of procedures, 
leading to higher traceability compliance within the ward.  
2.1.4.8 Latent factors 
It may also be worth noting some latent errors behind non-compliant behaviours. 
Technical aspects associated with latent failures include such things as equipment 
design, computer software and mobile and material facilities, the barcode on the 
transfusion labels were not water proof, this need to be transcribed onto the 
computer system manually when damaged by an medical laboratory assistant. One 
aspect of organisational failures stems from normal management issues. This 
includes the structure of the organisation, planning and scheduling, forecasting, 
budgeting and allocating resources.  
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3 Blood product tracking models  
This chapter first reviews the literature on the effectiveness of commercial 
traceability products. It then describes a survey of blood transfusion managers in 
NHS Trusts in North East England that gathered information about the actual 
process of traceability from professionals in the healthcare sector. The data 
gathered was used to inform the choice of traceability processes implemented by 
the Trust and described in Chapter 4. The purpose was to evaluate the error 
detection level, robustness, sampling techniques and the secondary outcomes of 
the blood tracking systems available. 
3.1.1 Introduction 
The aim of the literature review was to determine the range of blood tracking 
systems available and to summarise the evidence on the effectiveness of these 
systems. The specific objectives were:  
 To compare traceability procedures with the previous system or no system. 
 To assess performance in terms of percentage compliance, error detection 
levels and mistransfusion events. 
 To assess secondary measures such as cost-effectiveness, robustness and 
acceptance by staff members. 
The review included any studies that evaluated the outcome of a traceability 
process. Traceability processes could include electronic tracking systems or paper-
based methods. I included both randomized controlled trials and non-random trials, 
but as it was unlikely there would be many studies of this type, I also reviewed 
post-use evaluation reports and uncontrolled before-and-after studies. 
3.1.2  Method 
The review sought to identify all papers related to tracking systems for blood 
transfusion. I used search engines such as Medline (1966-2012), EMBASE (1980- 
2012) and CINAHL® (1982-2012), the Cochrane Library and the transfusion 
evidence library, which contains the National Health Service Blood and Transplant 
systematic reviews and Health Business Elite texts.  
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The search terms used were traceability (including tracking*, traceable*, tracking 
system or vigilance), blood (including haem*, transfusion, red cell, blood* or blood 
products*), haemovigilance (or vigilance*) and blood products (including red cells, 
blood* or blood products*). In addition, the search included the websites of medical 
companies that produce well-known tracking systems and a manual search of 
conference proceedings up to 2012. The references of full papers were identified 
electronically and also included in the review.  
The data collected related to the number of beds, number of blood units transfused, 
the need to trace blood products leaving the hospital (for external or home use), the 
quality of the study, the date of implementation and description of the new system, 
the system being replaced and outcome data. Studies were graded according to 
quality i.e. designed and outcome. Controlled studies were considered to be better 
quality than uncontrolled. Before-and-after and post-evaluation were both 
considered as uncontrolled studies.  
3.1.3  Results 
The initial review identified 378 references. Of these, 106 were found to not be 
relevant to the research question and were removed. The remaining 272 
references were screened for eligibility against predefined criteria. Twelve 
references were identified to be of particular interest. These are described in detail 
in Table 3-1. 
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          Twelve studies  identified included in quantitative synthesis
Records identified 
through database search 
(n = 378) 
Additional records identified 
through other sources (n =106) 
Records after duplicates removed (n =272) 
Records screened (n =30) 
Full-text articles assessed for 
eligibility (n =12) 
Studies included in 
quantitative synthesis (n =12) 
Records excluded (n =18) 
Full-text articles excluded 
(n = 0) 
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Table 3-1 Results of the literature review 
Author Method Type of 
traceability 
Sampling Outcome 
Royal 
Bournemouth 
and Christchurch 
Hospitals, 2010 
Before and 
after evaluation 
Olympus 
electronic 
tracking 
42 wards 
across two 
hospital 
sites 
Improved traceability 
compliance from 
70% to 100% 
Davis et al., 2009 Radiofrequency 
technology 
Tag and labels 
readability 
Blood 
centre 
Radiofrequency 
improves tracking  
Uriz et al., 2011 Evaluation  Tracking 
system 
EIS gricode 
520 beds 
hospitals 
Improved traceability 
compliance from 
48% to 99% 
Doughty & 
Hitchinson, 2010 
Before and 
after evaluation 
Transfusion 
practitioner & 
MLA( blood 
handler) 
600 units of 
blood 
Attained from 89% 
to 100% traceability 
compliance. 
Bachs et al., 
2009 
Pre and post 
evaluation 
Grifols – bar 
code reader 
400 beds Improved 
compliance from 
61% to 94%. 
Askeland et al., 
2008 
Pilot  Barcode 
tracking 
system 
Not 
specified 
Incident reporting 
reduced by 60% per 
month 
Ingrand et al., 
1998 
Evaluation Paper based  390 units of 
blood 
Attained 81.9% 
compliance 
Hammadi, 2009 Retrospective 
evaluation 
Patient records 
checked for 
traceability 
compliance  
2200 units 
of blood 
Compliance 
increased from 32% 
to 80% 
Al Abdulrazzak et 
al., 2009 
Evaluation Data 
management 
system 
1500 blood 
bags 
Data capture was 
improved from 40% 
to 98% 
Murphy, 
Stanworth & 
Yanzer, 2011 
Before and 
after evaluation 
Handheld 
barcode 
Not 
specified 
11.8% to 
100%Improvement 
in patient 
identification 
Chan et al., 2004 Evaluation Barcode 
tracking 
system 
Not 
specified 
90% compliance 
Verret et al., 
1998 
Evaluation Tracking 
system 
2 hospitals 97% of products 
were traced 
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3.1.4 Discussion 
The study at the Royal Bournemouth and Christchurch Hospitals showed that 
traceability compliance had improved significantly by employing the Olympus blood 
tracking system. Prior to the implementation, only 70% of transfused blood could 
be traced. The blood tracking system enabled positive patient identification and 
consisted of modular software, 2-dimensional barcoding and a wireless personal 
digital assistance. The system was introduced on 42 wards in the Trust and 
improved traceability compliance to 100%. The team also anticipated that future 
financial savings would be made by the elimination of blood wastage and ultimately 
free up staff time in the transfusion chain. 
Davis et al. (2009) highlighted the benefits of Radiofrequency Identification (RFID) 
technology, which included the reduction of discarded product and enhanced 
visibility of large quantities of incoming stock. They claimed that more timely, 
detailed and accurate information would support „Lean operations‟. High frequency 
passive RFID technology was found to perform satisfactorily in blood centres and 
assessed as safe when used with red blood cells and whole blood derivatives 
platelets. However, they highlighted that additional research was needed to confirm 
the performance and safety of RFID at very low temperatures with plasma 
products. 
Uriz et al. (2011) carried out a retrospective study of blood transfusion services at 
their hospital. The Gricode® electronic identification system (EIS) had been 
implemented in order to improve services. The EIS comprised a portable reader 
with software tailored to the hospital‟s existing systems, sufficient storage space 
and the ability to transfer data to the transfusion service. It recorded the beginning 
and the end of the transfusion at the bedside and any adverse reactions. It enabled 
patient, document and sample identification, together with the blood products 
transfused and time tracking. Following the implementation of the new system in 
2005 high levels of traceability were obtained, ranging from 99.5% in 2005 to 
99.7% in 2008. Monthly analyses indicated that traceability was consistent. The 
failure of ward staff to perform controls was also assessed in a subsequent 
analysis. The emergency room failure rate was above 20% due to the malfunction 
of the reader and the loss of data. The neuroscience unit failure rate was 25%, 
although only a few transfusions were performed by the unit. 
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The transfer of data between hospitals and National Blood Service is emerging in 
the U.K blood services but in its early stages. This will provide a complete 
traceability of blood products in the future, lately we could assess patient‟s serology 
reports from the NBS and check blood products issued to hospitals across the 
country, and this is a beginning of total traceability within the health sector.   
Doughty and Hitchinson (2010) described blood handling practices across several 
sites serving one Trust and eight smaller sites. A medical laboratory assistant was 
employed to handle the product, collect daily information from the ward and 
reconcile it with the blood issue forms. A transfusion practitioner was also 
appointed to deliver training to key groups of staff. They suggested that factors 
contributing to good compliance included the appointment of a hospital transfusion 
practitioner, electronic prescribing, a medical laboratory assistant in clinical units, 
timely feedback and reinforcing success. The cost effectiveness of the full tracking 
system requires further exploration. 
Bachs et al. (2009) evaluated the safety transfusion system and traceability 
compliance following the implementing of improvement measures. A tracking 
system (Gricode®) was employed in the transfusion department. The software could 
be accessed from the nurses‟ station and barcode readers were provided in 28 
areas of the Trust in order to scan the transfusion process. The data collected 
included the blood sample, the patient‟s identification bracelet, and the start and 
end times of transfusion. All data was downloaded on a daily basis to the main 
blood transfusion system where the whole process was supervised. The study 
showed that wards with low levels of compliance were those that carried out the 
fewest transfusions.  
Askeland et al. (2008) evaluated incident reporting associated with the introduction 
of wireless devices and barcoded labels to the transfusion process. Data was 
collected from before and after the implementation. Incident reports decreased 
from a mean of 41.5 reports per month in the six months before implementation to 
a mean of 7.2 reports per month after the implementation. Errors detected by the 
system included mis-scanning, skipped steps, wrong steps and identification errors. 
The authors estimated that the new system had caused the mistransfusion rate to 
drop to about once every 100 months. The bar-code based computerized tracking 
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system was shown to have reduced the proportion of errors in the transfusion chain 
and enhanced patient safety. 
Ingrand et al. (1998) conducted a pilot survey using information gathered from the 
medical record department in a French university hospital. The availability of 
transfusion information varied according to patient records and the type of ward. 
The study showed 81.9% traceability. The study also showed that traceability 
compliance differed according to the clinical area and was worst in surgical units. 
They recommended that robust, efficient change in the organization and 
information systems was needed. 
Hammadi (2009) described the tools used for evaluating traceability compliance in 
the medical sector. The patient‟s case notes, transfusion card and the transfusion 
register were used to evaluate the final destination of transfused blood. The study 
found that with the introduction of an electronic tracking system, the rate of 
traceability compliance improved from 39% in 2001/2002 to 83.3% in 2006. 
Al Abdulrazzak et al. (2009) conducted an evaluation of 1,500 red cells issued by 
the Kuwait Central Blood Bank. Prior to the introduction of the Data Management 
System (DMS), one hospital discarded all traceability records, while a second did 
keep some but a lot were missing. The rates of missing data were 87% and 40% 
respectively. After the DMS installation both hospitals were provided with a list of 
products supplied/received and were requested to check individual traceability 
records. Traceability compliance was found to have increased to 98%. The DMS 
implementation had resulted in a significant decrease in the number of missing 
records in both hospitals. The study recommended that manual records should not 
be discarded, but should be archived for easy access and retrieval. 
All methods of traceability system from this systematic review had improved 
traceability compliance to a varied degree. The introduction of interactive training 
and prompt built into this tracking system will be a useful innovation to improve 
compliance and also a barrier to minimise poor compliance in areas of low usage of 
blood product as identified by Bachs and colleagues. It is also important to identify 
failure rate of electronic tracking system, an incident was identified in the 
emergency room highlighted by Uriz et al., 2011. The use of electronic tracking had 
improved traceability compliance in most of studies, but the occasional failure rate 
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requires a risk assessment and further exploration of the limitation of this systems. 
Askeland et.al, (2008), also identified incidents such as mis-scanning of blood 
products, skipped steps and wrong steps. This shows the vunerability of this 
system.  
3.2 Commercial software products 
As early as the 1970s, Sherer et al. (1977) described studies that implemented 
prototype handheld bedside donor-recipient identification systems, but none of the 
systems proved acceptable under the clinical conditions. Since then, only small-
scale experiments have been reported, which makes it difficult to compare the 
effectiveness of different technical approaches.  
Murphy et al. (2004) highlighted that the current safeguards to prevent 
mistransfusion are inadequate. Minimising transfusion errors requires a co-
ordinated effort from all stakeholders to enhance patient safety throughout the 
transfusion chain. Automated identification and data capture systems such as 
barcoding and radiofrequency identification (RFID) can be a key enabler in 
reducing errors in blood transfusion, although the limitations of the technology have 
proved to be a barrier to widespread adoption (Hopkins, 2005).  
3.2.1 Barcode tracking systems 
Gradual progress has been made in the last decade to apply barcode technology to 
patient identification and transfusion medication safety. Barcode systems consist of 
a handheld terminal, a barcode reader, a biometric sensor for reading fingerprints 
and a keypad. The biometric sensor records the fingerprints of hospital staff and 
the patient. The system makes it possible to identify and check which blood units to 
assign to patients. Patients can be easily identified whether they are conscious or 
unconscious. The technology is a widely used, stable and inexpensive means of 
machine readable identification. Several commercially available products have 
been deployed by hospitals and others are in development (Aller, 2005). Progress 
in forward-looking hospitals is being stimulated by products that have been 
specifically developed for the healthcare sector (Table 3-2).  
Table 3-2 A sample of commercial products using bar-code technology.  
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Company  Website 
AMT Systems http://www.amtsystems.com 
Transfuse ID  
Becton Dickinson http://www.bd.com/bdid/ 
Biologics http://www.biologicsinc.com/ 
Olympus BloodTrack  
Grifols http://grifols.com/ 
Korchek Technologies http://www.korchek.com/ 
Lattice Corp MediCopia http://www.lattice.com/ 
Haemonetics http://www.haemonetics.com/ 
Barcode tracking systems such as I-TRAC (and its modified versions Safe Track 
and I-TRAC Plus) consist of a barcoded wristband for patient identification and a 
handheld portable data terminal. The patient and the blood pack are identified 
using a scanner and the information is downloaded via a portable printer.  
Such a system was installed at the Georgetown University Hospital in the United 
States (Sandler, Langeberg & Dohnalek, 2005), while Chan et al. (2004) described 
a simplified bar-coded method that reduced error rates in a Hong Kong hospital. 
They reported that although compliance averaged 90%, problems were 
encountered with battery failures of the handheld device. In the United States, the 
University of Iowa evaluated a similar system and found that it was ten times better 
at capturing errors than the manual process. Despite the advantages of barcode 
systems, some studies found that traceability compliance did not improve (Nichols 
et al., 2004) as the barcodes on wristbands can be blurred and difficult to read. 
Barcode-based systems require that the wrist and blood unit be scanned each and 
every time; in urgent situations this can make the process very clumsy. 
The Tracesoft blood tracking system was designed to scan blood packs to be 
delivered to wards. It was designed to search for blood packs and identify their 
location. A central server provides a web-based view of activity, controls access to 
blood fridges and bedside software. All tracking base and bedsides devices are 
linked to the central server in a real-time thereby providing an overview of all 
product movements. Each process has a full audit trail and the system can send 
both visual and audible alerts to a nominated workstation. Full access control is 
incorporated into the system. Every user has a login and password. It also provides 
fine-grained control over access rights.  
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In 1991 the Albert Einstein College of Medicine in the United States evaluated the 
BloodLoc system. In this system, an alphabetic code taken from the patient 
identification bracelet must be used to access the assigned blood unit. The same 
system was implemented at the Dartmouth-Hitchcock Medical Centre in New 
Hampshire (United States) and the Gaetano Pini Orthopaedic Institute in Milan, 
Italy (Mercurialli et al., 1996). 
3.2.2 Radiofrequency tracking systems 
Another method is radiofrequency identification (RFID) to link barcodes or 
microchips to palm computers. In the mid-1990s, little attention was paid to RFID 
but since then it has gained momentum as the cost of implementation has 
decreased. Most studies show that the technology is suitable for transfusion 
medicine but its implementation may present challenges. All blood bag trials have 
used a frequency of 13.56 MHz, because of the ability to take readings through 
fluids. Trials have tested the durability of tags under real conditions, such as 
centrifugation, temperature changes and irradiation. There appear to be no trials 
that investigated the entire blood chain, from blood bag manufacturers to donation, 
production, storage, distribution and transfusion. Consequently, no studies have 
been identified that determine the return on investment from RFID. 
Radiofrequency tracking systems have several advantages over barcoding in terms 
of patient safety. RFID chips can hold more data than a barcode and can include 
more information such as patient allergies, blood needs and any special 
requirements. Secondly, unlike a barcode, RFID does not require the use of light 
beams and RFID chips are interrogated through simple proximity to an electric 
reader. Dzik (2005) and Sandler, Langeberg and Dohnalek (2005) described the 
radiofrequency (RFID) identification method using a frequency of 13.56MHz. Blood 
bag tags were integrated into the blood bank computer system. Tags and patient 
wristbands were read by a built-in radiofrequency reader.  
There are two kinds of RFID technology. In Active RFID the chip is powered by a 
battery and emits energy that can read over a distance, this is commonly used to 
track assets within an establishment. Passive RFID technology is more suited for 
blood bags and patient identification as it emits no energy. Tags are read only 
when in close proximity to the reader. At Massachusetts General Hospital (United 
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States) a pilot study was conducted using passive RFID. A bedside reader was 
used to identify the blood bag and to provide feedback on the match between the 
identity of the patient and the blood bag (Dalton, 2005). 
RFID was used at Saarbrucken Hospital in Germany to track blood bags, record 
transfusions and ensure that patients received the right blood, this was a small 
study and the effect of durability of the tags, centrifugation, temperature changes, 
irradiation was not investigated (Wessel, 2006). Hospital staff attached self-
adhesive labels to all blood bags arriving at the hospital. The labels contained 
passive RFID chips with two kilobytes memory for storing unique identification 
numbers. The Return of investment is a big issue with the use of RFID in 
transfusion medicine and this require full further evaluation. 
3.2.3 Limitations and challenges of barcode and RFID 
technology 
Although traceability should enable tracking of all phases of the transfusion 
process, it can also breach privacy. Patient‟s data are stored on chips  and 
transmitted at different frequency depending on the reader and carrier. The full 
security of this data have not been fully evaluated, even though firewalls can be 
created to prevent access. 
Carriers and readers are an important aspect of tracking. Carriers come in many 
forms, such as barcodes, data matrices, RFID and smartcards and each carrier has 
its own standards. RFID, for example, uses three frequency ranges (125 kHz, 
13.56 GHz. and 900 MHz), each with advantages and disadvantages. Carriers and 
readers must be standardised if the codes they carry are to be easily read and 
stored. Moreover, there are still reliability problems with carriers. As yet, there is no 
ideal carrier; the choice depends on physical and environmental constraints as well 
as robustness and cost. Despite a lack of reliable studies, RFID is a very promising 
technology and may have a significant impact in healthcare (Fanberg, 2004, p.43).  
In the United States, the American Food and Drug Administration requested the 
national RFID consortium to subject blood products to radiofrequency energy in 
worst-case conditions to determine whether there was any in vitro adverse impact. 
The aim of the study was to ensure that any impact of exposure to the 
radiofrequency reader on blood safety could be assumed to be acceptable. Testing 
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included an evaluation of product heating and any key biochemical changes from 
exposure to an intense radiofrequency magnetic field for longer than 23-25 hours 
(Davis et al., 2009). 
The use of handheld devices to capture barcoded information from the patient 
wristband improves patient safety and minimises mistransfusion. The handheld 
device of a typical commercially available system receives and transmits 
information about patients and blood units. This requires an interface between the 
handheld device and the hospital network or a dedicated wireless network. Privacy 
and security are concerns with the use of both RFID and wireless technology. 
Other technological limitations include the implementation of firewalls to protect the 
RFID database, tag disposal and recycling and shielding RFID tag or tag reading 
areas with metal screens to prevent unauthorized access (Davis et al., 2009). The 
use of RFID on blood products is in its early stages, because of its return on 
investment cannot be ascertain, most studies have been carried out on red cells, 
the effect of radiation on plasma products requires further explorartion and effect of 
electromagnetic radiation on blood products is currently under investigation. The 
cost of installing a tracking system is becoming affordable and cost-effective since 
the inception of this study compared to RFID. 
 
 
3.3 Survey of blood bank managers  
This phase of the study aimed to provide information about the actual process of 
traceability and opinions from healthcare professionals. The data gathered was 
used to inform the choice of traceability processes implemented by the Trust and 
described in Chapter 4. 
Data was gathered through a self-administered questionnaire sent to blood bank 
managers working in NHS Trusts in North East of London. It aimed to answer the 
question, “What variables are associated with traceability compliance in NHS Trust 
hospitals in North East of London” (Appendix 6). Most of the NHS Trusts that 
participated in this study came from Brentwood user group. 
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The Homerton University Hospital NHS Trust clinical governance committee 
approved the study. Participants were informed in writing that their participation 
was voluntary and anonymous. Non-respondents were not followed up as it was 
felt that they should not have to justify their decision not to participate. 
3.3.1 Method 
Hospitals with no blood bank services were excluded from the study. Twenty-five 
questionnaires were sent to blood bank managers who were invited to participate 
on a voluntary basis. A covering letter was attached to the questionnaire explaining 
that all data collected would be treated anonymously and destroyed following 
analysis. The questions related to individual Trust traceability compliance and 
addressed issues such as bed capacity, the availability of a satellite fridge, whether 
there was a tracking system in place, its cost and training. 
Questionnaires were posted to participants together with a self-addressed 
envelope for the return of the questionnaire. Reminders were sent a month later to 
maximize the response. 
Completed questionnaires were numerically coded to facilitate the analysis and 
organise the results. Descriptive statistics were used to evaluate the sample. The 
data was not normally distributed; the Kruskal-Wallis test, Spearman‟s rank 
correlation coefficient and the Mann-Whitney U test were used in the analysis.  
3.3.2 Results 
The response rate was 64% (16 out of 25 trusts) and table 3-3 shows the 
demographics of the Trusts surveyed.  
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Table 3-3 Demographics of the 16 NHS Trusts surveyed. 
 Frequency (n=16) % 
Bed capacity 
1-100 1 (6.3) 
101-200 2 (12.5) 
401-500 7 (43.8) 
>500 6 (37.5) 
Trusts with satellite fridges  
Yes 13 (81.3) 
No 3 (18.7) 
Transferring blood to other sites  
Yes 16 (100) 
Tracking system in place  
Paper tracking 12 (75.0) 
Electronic tracking 4 (25.0) 
Cost of tracking system in place  
Medical Laboratory Assistant 9 (56.3) 
Not known 7 (43.7) 
Hospital staff trained in the collection of blood  
51-75% 8 (50.0) 
76-100% 8 (50.0) 
Red cell units transfused in the last 12months  
>5000 13 (81.3) 
<5000 2 (12.4) 
Unknown 1 (6.3) 
Average traceability compliance  
<75% 1 (6.3) 
>75% 15 (93.7) 
Feedback mechanism to users  
Yes 13 (81.3) 
No 3 (18.7) 
Audit of the transfusion process  
Yes 13 (81.3) 
No 3 (18.7) 
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Table 3-3 shows that 44% of the  Trusts had a bed capacity of 401-500, similar to 
the Homerton University Hospital NHS Trust.  
Demographic data was not normally distributed; hence the Kruskal-Wallis test was 
used to compare the relationship between bed capacity and average traceability 
compliance. The number of beds on the wards did not influence compliance (p = 
0.64; median 0.62). 
All respondents confirmed that they transferred blood products to other sites or 
hospitals, however the transfer of blood products to satellite hospitals did not 
influence traceability compliance (p = 0.44). 
Seventy-five per cent of respondents said they had a paper-based tracking system, 
while 25% said they were using electronic tracking. The analysis showed that there 
was no relationship between electronic tracking and traceability compliance (p = 
0.52; median = 0.25). It was evident that although electronic tracking and paper-
based methods improved traceability compliance, the cost of the two systems 
required further exploration. 
Regarding the percentage of staff trained in the collection of blood products, 
50% said the percentage was 51-75%, while the other half assessed it to be 76-
100%. The Trusts with most trained staff had better traceability compliance as 
Spearman‟s correlation showed there was a positive correlation between training 
and traceability compliance but not clinically significant (r = 0.48; p = 0.06). 
Eighty-one per cent of respondents said that their hospital had transfused less than 
5,000 red cell units in the past year. Twelve per cent reported transfusing more 
than 5,000 red cell units and 6% did not know the number. There was positive 
correlation between transfused units and traceability compliance (r = 0.54; p = 
0.03).  
Ninety-four per cent of respondents said that average traceability compliance was 
greater than 75%. At the same time, few Trusts were working towards improving 
their compliance which suggested that both tracking methods (paper and 
electronic) improved traceability compliance. 
 75 
 
3.4 Discussion  
The objective of this review of current practice was to identify and explore the 
effectiveness of different blood product tracking models to inform the choice of 
traceability processes implemented by the Trust and described in Chapter 4.  It was 
evident that staff training within the transfusion chain remained a big issue in some 
of the Trusts surveyed, and not all staff had been adequately trained.  
Overall, the results showed that audits, regular feedback, traceability methods and 
the percentage of trained staff positively influenced traceability compliance. 
Nevertheless, there are limitations related to data collection and the transferability 
of the study. The sample size was small and the selection of participating Trusts 
was not representative, which might have skewed the data. Participant‟s were 
assured that all respondents will not be identified, there is tendency that 
compliance might have been overstated if they felt that they might be identified or 
data might be used outside the purpose of this study. The NHS Trusts with good 
compliance will likely give more information how compliance was achieved. Error 
detection level within NHS Trusts remains a concern, hospital laboratories with high 
error reportable level tends to come under scrutiny by regulatory bodies, 
consequently this has led to underreporting of incidents as identified by SHOT, 
2011. Further studies will be required on a larger scale to assess the transferability 
and problems with traceability compliance . 
3.4.1 Literature review 
Of the 12 studies identified in the literature review, nine included data about post-
implementation traceability compliance. However, the quality of the evidence varied 
and was subject to limitations. First, some studies did not specify the medical 
speciality concerned. In other studies a before-and-after comparison was made, 
but the lack of concurrent controls meant that there could be alternative 
explanations for the change in the compliance rate. Moreover, before-and-after 
studies and non-blind studies are prone to a reporting bias. One study simply 
reported post-implementation compliance rates. There were inconsistencies in the 
descriptions of how the studies were conducted and outcomes were reported. In 
addition to the limitations of individual studies, there were several potential biases 
in the review process itself. Relevant data may not have been captured either 
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because it was not provided or because it was not published. It was evident that 
both the tracking system and the paper-based method shown in Table 3-1 
improved traceability compliance; therefore the cost-effectiveness of both systems 
needs further exploration. The tracking system also freed up staff time by sorting 
blood products, reducing wastage and increasing the use of old stock.  
3.4.2 Tracking methods 
Documentation and tracking methods are important as they many improve 
compliance. The review of records or audits has conventionally been a way of 
performing quality assurance checks and documenting patient outcomes. The audit 
of records against predetermined criteria can be an important method in identifying 
errors or near miss events. In the survey of blood bank managers, 75% said they 
had a paper-based tracking method, while 25% said they were using electronic 
tracking. While this may be an area for improvement in compliance, technology is 
not a panacea. Moreover, electronic tracking may be an expensive option, reflected 
in the fact that 44% of respondents said they did not know the cost of the current 
system.  
RFID technology may be a valuable tool, if it is affordable. It captures the 
movement of all blood products using a reader and carrier. It keeps patient 
information safe and secure, reduces the turnaround time for blood products 
tracing and helps to track and sort blood products in time and date order, hence 
reducing wastage and improving stock management.  
Self-assessment may be another way to improve practices that are likely to lead to 
increased compliance. Self-assessment must be carried out regularly and 
monitored so that incidents can be reported immediately. To achieve secure and 
traceable procedures concepts regarding quality, security and efficiency must be 
incorporated into the process itself. On the other hand, the members of staff that 
are involved in the transfusion process must initiate action. Practices and methods 
must be established to prevent errors. Furthermore, it is essential to have a robust 
policy, implement systems that support the policy, assess the skills of staff 
members against national standards and audit the process. 
The cost benefit of RFID in light of its capability is enormous but requires NHS 
funding. 
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4 New system implementation (Method 2) 
The Trust had initially attempted to meet the requirements of MHRA guidelines 
using a paper-based method, which failed to achieve 100% compliance. As the 
guidelines required all Trusts to achieve 100% compliance this had become a 
concern and the hospital management and transfusion teams were made aware of 
the situation.  
The Trust was not able to explore the electronic tracking systems described in 
Chapter 3 because of lack of funding for this project. There were doubts about 
whether it would be able to resolve the non-compliance issues. Consequently, the 
Trust management asked the transfusion team to provide a business case for 
alternative methods in order to achieve full compliance. This chapter describes and 
evaluates the changes that were made to quality control processes to improve 
traceability compliance at the Trust.  
The new system consisted of an air-tube that was primarily designed for sending 
samples from wards to the pathology department. In 2009 it was extended to 
various other wards in the Trust who were asked to use it to return the labels from 
transfused blood units. Every ward within the Trust was equipped with an air-tube 
station and canisters. Samples and transfused labels sent directly to the blood 
transfusion reception arrived within 60 seconds (Figure 4.1). An evaluation showed 
that this brought about a huge improvement in traceability compliance  
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Air-tube base
 
Ward network
 
Figure 4.1 Air-tube system installed at the Trust 
The system enables the fast delivery of labels from transfused blood units to the 
transfusion laboratory and labels from the wards to the pathology department. This 
means that wards can send labels without the need for a porter or a laboratory 
assistant. The layout of the system is flexible and transfers can be made at any 
time of day. The canister is bar-coded to allow redirection to the right ward and the 
system can be easily altered or extended according to the needs of the Trust. 
4.1 Quantitative assessment of traceability compliance  
4.1.1 Method  
A two-year follow-up study was undertaken from 2009-2010 to evaluate the impact 
of Method 2 on traceability procedures. Information regarding blood transfusions 
was gathered and reviewed after every transfusion episode and the subsequent 
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discharge of the patient. Data was extracted from the blood transfusion information 
system and included the destination of all blood sent to the wards and all the blood 
units assumed to have been transfused (included missing tags and destroyed 
labels). Traceability compliance was calculated as the number of units successfully 
traced as a percentage of all units issued from the blood fridge.  
All wards using blood products in 2009-2010 were included in this study. 
Participation was voluntary. All wards that carried out more than two transfusion 
episodes per week were included in the study, other wards were excluded. The 
data for each ward was extracted from the blood transfusion laboratory information 
system on a monthly basis.  
The data extracted consisted of the total number of units where the final destination 
could be traced (T), minus those assumed to have been used (U), divided by the 
total of number of blood units issued (I). I implemented a database to record all the 
units transfused and calculated the percentage compliance using SPSS (SPSS, 
2010) software.  
Descriptive statistics was used to answer the research question to determine the 
mean and standard deviation of the annual compliance rate for each ward and 
visually illustrating data using graphs. The variance analysis was used to 
investigate the predictors of compliance at user group level (i.e. low, medium and 
high usage groups) and the one-sample t-test compares the mean score of method 1 
and method 2 average compliance. 
4.1.2 Results 
Over all wards and both years the mean compliance rose to 91% (standard 
deviation 8.7%); although in 2010 there was a sharp increase in compliance (from 
82–100%). 
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Table 4-1 Average ward compliance 2009–2010.  
Ward Blood units  
transfused  
2009-2010 
Average 
compliance  
2009-2010 (%) 
Adult R 138 55 
St Jose 224 82 
Cox 188 86 
Halley 712 86 
Turpin 163 88 
Theatre 505 90 
Templar 295 90 
Deliver 870 91 
Mau 196 91 
CCU 137 92 
Lloyd 646 92 
Acute C 1358 93 
Day Sta 197 93 
Defoe 148 94 
Priestly 503 94 
AE 1409 95 
Edith 666 95 
Thomas 321 95 
Intensive 963 96 
Lamb 264 96 
Aske 282 97 
Medical 2650 97 
SCBU 2273 98 
Haematology 292 100 
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Table 4-2 Percentage compliance 2009–10.  
Year Percentage compliance 
 n = 24 
Standard 
deviation 
2009 82.0 (17.2) 
2010 100.0 (0.0) 
A one sample t-test was carried out to compare the two methods. These results 
showed that overall compliance rates improved with the introduction of the new 
traceability method (see  
The mean compliance for Method 1 was 65% with a 95% confidence interval 
(54.1–70.7; standard deviation 11.7%) while for Method 2 it was 91% also with a 
95% confidence interval (86.9–93.3; standard deviation 8.7%).  
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Figure 4.2 Comparison of ward traceability compliance using Methods 1 and 2  
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Figure 4.3 shows 2012/13 the average traceability compliance within the Trust 
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1- Low user group
       2- Medium user group
  3- High user group
 
Figure 4.4 Usage group traceability compliance under Method 1 
1- Low user group
       2- Medium user group
  3- High user group
 
Figure 4.5 Usage group traceability compliance under Method 2 
Variance analysis showed that there was no significant difference in the 
compliance means of the low, medium and high usage groups during the period (F 
= 0.70; p = 0.51) and this relationship was maintained each year. 
4.2 Further interventions to improve compliance 
Two further interventions were made to improve traceability compliance. These 
were the appointment of a Medical Laboratory Assistant (MLA) and the 
implementation of medical records follow-up procedures. 
4.2.1 Medical Laboratory Assistant 
A business case was approved by the hospital management early in January 2009 
to employ a member of staff to follow up missing labels, track patients and collect 
information on every blood unit transfused in the Trust on a daily basis. The 
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employment of the MLA also had a positive impact; traceability compliance 
improved to 91%. 
4.2.2 Medical/electronic processing records 
A small audit was conducted in 2010 to identify what had happened to labels that 
went missing following transfusions, which could not be accounted for by ward 
staff. The audit involved a sample of 20 missing labels.  
I requested the patient‟s medical notes to confirm the final destination of the 
transfused product. This required a day‟s notice to receive the notes from the 
medical records department and took an average of 45 minutes per note to find the 
information required. Transfusion information for all 20 missing labels was identified 
in the patient‟s notes and this finding formed the basis for a discussion with the 
Trust‟s management about the appointment of additional staff. The Trust approved 
the appointment of an additional MLA in 2010 in support of the aim to achieve full 
compliance. The role of this MLA was to monitor all instances of unreturned blood 
labels. Subsequently, unreturned labels or missing blood labels were followed up 
by requesting the patient notes from the Trust‟s medical records department, and 
checking the wards and operating theatres for disposed labels.  
4.2.3 Transfusion nurse specialist 
The training of staff involved in the transfusion chain was the responsibility of a 
part-time specialist transfusion nurse. The Trust management also agreed to 
convert this post to a full-time post.  
4.3 Discussion 
Although between 2005-08 traceability compliance improved in some areas of the 
Trust, it remained only fair in other wards. I had hoped that the clinical units where 
compliance was poor would be visited daily but this was not achievable due to staff 
shortages. In 2009-10, major changes were introduced following discussion with 
the Trust‟s Chief Executive at a monthly Hospital Transfusion meeting. The air tube 
system designed for sending samples from Accident and Emergency and operating 
theatres was extended to all wards within the Trust; this was followed by approval 
for a full-time Medical Laboratory Assistant and a full-time Transfusion Practitioner. 
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Shulman, Saxena and Ramer (1999, p.595) highlighted that the main elements of a 
quality approach for preventing identification errors include having a transfusion 
safety officer, regular training, competent staff, system re-engineering and standard 
operating procedures. Similarly, Doughty and Hitchinson (2010) identified the 
factors associated with good levels of compliance as the appointment of a hospital 
transfusion practitioner, electronic prescribing, having a medical laboratory 
assistant in clinical units, timely feedback and reinforcing success. In the light of 
these studies there are ongoing initiatives in the Trust to develop better testing and 
assessment of competency for both clinical and laboratory staff.  The major 
changes made within the traceability procedure had improved our compliance to 
100% as shown in fig. 4.3. 
SHOT report (2011) pointed out that continued errors in the basic transfusion 
process were disappointing given the various national initiatives and standards 
introduced in the past ten years. They highlighted communication failures between 
clinical and laboratory staff, and sharing care between hospitals or between 
hospitals and the community as ongoing problems. In the project, good 
communication helped to demonstrate that the new system had helped to solve the 
issue of non-compliance.  
Simple, innovative methods were developed to alert staff in the transfusion chain. A 
barcode label was created to simplify data input into the hospital‟s information 
system and minimise errors. This was attached to every blood product issued. 
4.4 Change management  
This project attempted to ensure the rapid adoption of traceability compliance by 
wards in the Trust and improve the attitude of stakeholders to patient safety. A 
major challenge of the project was to instigate a change in staff behaviour, 
encourage them to move away from ritualistic practice and demonstrate that 
change can be a good thing. It was difficult to introduce change in such a complex 
setting and I encountered difficulties in breaking old habits.  
Change management has been an integral part of organisational theory and 
practice for a long time. Indeed, some suggest that the future survival of all 
organisations will depend on their ability to successfully manage change (Burnes, 
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1996; Peters, 1989; Toeffler, 1983). Organisational change is usually required 
when there are changes in the environment in which an organisation operates. 
However, it can be also be brought about by environmental factors such as 
political, economic, sociological and technological variables (Jury, 1997, p.27).  It 
was anticipated during the design of this study that managing change will not be a 
problem. Consequently, there was resistance from senior clinicians within the Trust 
and complaints from the wards. In my role as a BMS I had to change the approach 
of frontline staff and explain our intentions in plain language. The study also 
assisted getting through to core staff within the Trust to explain the changes that 
need to be met. 
Orlikowski and Hoffman (1997, pp.11–21) proposed an improvisational model for 
managing technological change. The model is based on the assumption that 
technological changes constitute an ongoing process and that changes associated 
with an ongoing process cannot be anticipated in advance.  
Evans (2000) highlighted that in the twenty-first century change leadership is not 
simple. He sees modern leadership as a balance between a track record of 
success and the ability to admit mistakes and handle failure well. He argues that 
leaders need to balance their efforts across three dimensions of organisational 
change, namely: 
 Outcomes: Developing and delivering outcomes. 
 Interests: Mobilizing influences, authority and power. 
 Emotions: Enabling people and organizational culture to adapt. 
4.4.1 Psychodynamic approaches to change 
4.4.1.1 The Kubler-Ross model 
The idea that human go through a psychological process during change was first 
introduced by Kubler-Ross (1969). The word „psychodynamic‟ is used to express 
the idea that when facing change in the external world an individual can experience 
a variety of internal psychological states. Kubler-Ross noted that patients would 
typically go through five stages as they came to terms with their prognosis. 
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Figure 4.5 The process of change and adjustment. 
Source: Based on Kubler-Ross, 1969 
People faced with a potential change do not actually take it in, but become 
emotionally numb and have a sense of disbelief. In a sense they shut down and 
avoid thinking about the news. In the Trust, the clinical staff felt that additional tasks 
had been added to their workload and became resistant to further information. 
When people allow themselves to acknowledge what has happened, they enter a 
stage of anger and begin to ask themselves, why me? They focussed their anger 
and frustration externally. Anger is a way of displacing real feelings to a situation. 
Within the Trust labels were misplaced and discarded. 
When they have exhausted themselves by attacking others or themselves, people 
still try to wrest back some control of the situation or their fate. Kubler-Ross 
identified bargaining as the next stage. The person desperately looks for something 
to remedy the situation. In the Trust, it was made mandatory to account for all 
transfused labels; a clinical incident was raised whenever a label was not returned. 
Staff become depressed when it becomes clear that no amount of bargaining is 
going to provide an escape route from the situation, Kubler-Ross observed that 
many people move out of depression into a fifth stage of acceptance. Within the 
Trust, clinical incidents raised were investigated and corrective action was initiated.  
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4.4.1.2 The Satir model 
Satir et al. (1991) observed individuals and families experiencing a wide range of 
changes. The model not only has a number of stages but also highlights two key 
events that disturb or move an individual. These are the „foreign element‟ and the 
„transforming idea‟. The study describes the initial stage as the status quo. This 
changes when something new enters the system. Satir calls this a „foreign element‟ 
in the sense that a factor previously not present is introduced. A period of chaos 
ensues. While the external world continues to function the individual‟s internal 
world is turned upside down. During the period of chaos, we see elements of anger 
and disorganisation permeating the individual world. Feeling of dread, panic and 
despair are followed by periods of apathy and a sense of pointlessness. 
However, the integration of new air tube system within the Trust brought in a bit of 
ease to the staff on the wards and visits by the MLA to the wards was another 
assurance that we are introducing innovation to ease the workload in the clinical 
areas of the Trust.  Satir et al. (1991) concluded that once the transforming idea 
has taken root, the individual can begin the journey of integration. This period of 
integration requires the new world order to be assimilated into the individual‟s own 
world. As time goes on, the new structure is bedded into the organisation, roles and 
responsibilities are clarified, new objectives and ways of working are specified and 
results are achieved. A new status quo is born.  
4.4.1.3 Force field analysis 
Kurt Lewin (1951) developed the idea of organisational change. Lewin introduced 
the idea of force field analysis, which examines the driving and resisting forces in 
any change situation (Figure 4.6). The underlying principle is that driving forces 
must exceed resisting forces if change is to happen.  
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Figure 4.6 Lewin's force field analysis applied to the Trust 
Lewin suggested that the organisational change occurs in three stages; the first 
stage is „unfreezing‟ the current state of affairs. This involves defining the current 
stage, highlighting the driving forces and the resisting forces and identifying the 
desired outcome. The second stage is the move to a new state through 
participation and involvement. The third stage is refreezing and stabilizing the new 
state of affairs by setting policy, rewarding success and establishing new 
standards. Driving forces formed the focus of the implementation phase, and I did 
not foresee any additional resisting forces. However, resistance did come from 
clinical areas of the Trust, and it had a negative impact on the Trust‟s average 
compliance in 2008. Figure 4.6 highlights resisting forces such as staffing issues, 
lack of funding and poor compliance. Frontline clinical staff members were not 
comfortable with the approach. Some senior staff opted out of blood transfusion 
activities due to their inability to comply with basic instructions, while most staff 
members asked for improvements to the methodology. 
4.4.2 Justification for change 
Despite dramatic improvements in blood safety and the low risk of viral 
transmission, infection and mistransfusion are still major concerns. The Blood 
Safety and Quality Regulations (2005) were the key driving force for implementing 
change. These regulations require full traceability of blood and blood components 
from the point of receipt by the hospital. Additionally, the final destination of all 
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components should be retained in a readily available and recoverable format for 
thirty years.  
4.4.3 Funding and training 
It is important to note that funding was a concern. Hiring additional staff to help to 
achieve compliance with the new regulations was a challenge for the Trust. The 
potential benefits of electronic tracking systems will be explored when funding 
becomes available and a cost-benefit analysis will have to be carried out.  
An in-house training session was developed for all staff involved in the transfusion 
process and it is now a mandatory requirement that only trained staff members can 
collect and administer blood products.  
4.5 Clinical implications 
This study has shown that several aspects of blood product traceability require 
more rigorous research. For example, there are few studies that have looked at 
traceability procedures after a blood product leaves the blood fridge. The impact of 
temperature and electromagnetic radiation on blood products has not been fully 
investigated and bacteria contamination has only been investigated. Few studies 
have examined how blood products were traced offsite or when patients are in 
transit or at home. 
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5 Application to practice 
To reiterate briefly, the aims of the project were to explore reasons why traceability 
compliance was poor within the Trust and identify why compliance varied between 
wards. The key objectives were: 
 To assess traceability compliance for blood products in all wards of the 
Trust and identify the processes that led to poor compliance.  
 To select an appropriate traceability model and labelling procedure for 
blood products.  
The results of the study showed that blood transfusion is a complex chain that 
involves many stages. Some key variables were identified that had immediate 
financial and business benefits i.e. there was a drop in wastage of blood within the 
Trust, staff communication with transfusion department improved, more staff 
phoned the department and were willing to get involved in the training and 
assessment programme.  
It also showed that training varied between wards and few wards were equipped 
with a trainer. In fact, the majority of ward staff only had a formal introduction to 
blood transfusion during their induction when they were first employed by the Trust. 
Consequently, ward staff were not sure how to return transfusion labels to the 
laboratory. Wards that carried out a large number of transfusions were more 
compliant that wards that only did them occasionally.  
The study also showed that traceability processes vary from Trust to Trust and the 
most Trusts anticipated that they would request tenders for an electronic tracker 
system in the future. 
The study‟s objectives were as follows: 
To examine the transferability of this evaluation and reflect on the impact on 
practice. 
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5.1 Evidence of achievements 
As a result of the project, the following objectives were met. 
Objective 1. 
To undertake a six year cohort study to identify the risk factors of traceability 
compliance for blood products within all wards of the Homerton University 
Hospital NHS Trust and identify the processes that lead to poor compliance.  
 Specialist transfusion nurse: It was evident from my report that, the 
wards with a trainer had better traceability compliance. The report of my 
findings was sent to the Hospital Transfusion Committee, which agreed that 
we could submit a business case for a specialist transfusion nurse because 
the frontline staff lacked the skills in blood transfusion. It took a further three 
years to get funding but eventually the Trust approved full funding for the 
position. 
 Development of competency: Following the appointment of the specialist 
transfusion nurse, a skills assessment was developed to be taken by all 
staff involved in the collection and administration of blood products. 
Although the proposal was not welcomed by clinicians it eventually became 
mandatory. Training has begun, but only 20% of staff members have been 
assessed. 
 Provision of clinical supervision: There is now a system in place to 
support all staff involved in blood transfusion, day and night. Academic 
training has been provided to improve practice. The training is cascaded by 
the specialist transfusion nurse and credits are awarded to participants to 
promote professional development. 
Objective 2 
To select an appropriate traceability model and labelling procedure for blood 
products within the Homerton University Hospital NHS Trust.  
The Trust Chief Executive approved funding for the extension of the air-tube 
system to the various wards within the Trust. The evidence gathered from the 
auditing of patient‟s note resulted to the submission of a business case which 
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eventually led to the appointment of an MLA. This had impact on practice by 
improving the return rate of labels from 90% to 100% and also investigating what 
had happened to blood units with missing labels.  
 Air tube system: This was ordered by the pathology manager to improve 
the turnaround time of samples sent from the various wards. Ward 
managers were asked to use this traceability system to return labels to the 
transfusion laboratory as soon as the transfusion was completed. 
 Redesign of information technology: Transfusion labels and forms were 
redesigned to include the date, time and signature of the staff member that 
checked the product at the bedside before the transfusion began. Currently 
there are two different systems in place which do not comply with the 
requirement for full traceability of blood products.  
Objective 3 
To assess the impact on traceability compliance at the Trust. 
 Annual skills check: it has become mandatory for all staff to be re-
assessed annually to prove that they are fit to practice. In the event of non-
compliance they are re-trained and assessed before being allowed to 
collect or administer blood products. 
 Development of clinical guidelines: The Trust intranet has been updated 
to cover aspects of Blood Safety and Quality Regulations and provide links 
to examples of good practice, quality improvement and information about 
clinical audits on blood transfusion topics, monthly feedback of traceability 
compliance. 
Objective 4 
To evaluate the cost effectiveness of the traceability model. 
The cost effectiveness of the traceability model was not fully met in this study 
but the direct cost savings in wastage was evaluated in this study. I make a 
total of £67,790 saving over a 6 year period see Table 5-1. 
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The following sections provide an overview of the implementation of these 
recommendations, although it is not possible to provide complete details of the 
planning, development and implementation of each initiative. 
5.1.1 Specialist transfusion nurse  
The study demonstrated that the role of a specialist transfusion nurse is crucial in 
the delivery of an effective service. Results showed that wards with a trainer had 
better traceability compliance than wards with no trainers. It was also clear that 
supervision and training from a practitioner with skills in transfusion was an 
essential requirement. The final outcome of the research was initiatives designed to 
meet the need identified by the study. In particular: 
 Teach and support frontline staff throughout their induction and while 
working on the wards. 
 Offer information and support to frontline staff on a daily basis. 
 Promote a range of continuous professional development options for staff 
responsible for the collection and administration of blood and its products. 
 Assist staff in their training and become more proactive in identifying their 
learning needs. 
 Promote and offer clinical supervision for the collection and transfusion of 
blood products. 
 Liaise with transfusion laboratory scientific staff on clinical staff learning. 
 Plan, teach and support practice nurses throughout their induction training 
programme.  
This finding enabled the development of a tool for all frontline staff to encourage 
them to maintain a personal development plan. This initiative was in keeping with 
the requirement of the General Medical Services contract (Department of Health, 
2003). It also provided supporting evidence for progression through the knowledge 
and skills framework along within the Agenda for Change implementation 
(Department of Health, 2004). 
5.1.2 Skills assessment 
In response to concerns from the National Patient Safety Agency, the clinical 
governance committee suggested a training programme and competency 
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assessment designed to meet personal and professional accountability 
requirements. This initiative prompted the development of an in-house weekly 
training programme followed by a competency assessment. This new initiative 
enabled frontline staff involved in the collection and administration of blood to 
understand the issues, share their concerns and challenge evidence, which led to 
improvements in the services provided by the Trust. In addition, a forum was 
organised to improve awareness of blood transfusion services within the Trust. 
5.1.3  Redesign of information technology 
It was apparent that frontline staff involved in the transfusion chain lacked the skills 
to handle evidence-based information. The hospital intranet was updated with more 
information on transfusion services and hand-outs were made available. Nurses 
were encouraged to enter all records of transfusion procedures into the information 
system for accurate traceability. 
5.1.4  Medical laboratory assistant (MLA) 
The data obtained from this research revealed that there were various methods for 
returning transfusion labels to the department. It was evident that although some 
labels were left on the wards and others were found in the disposal bin the majority 
were sent through the air-tube system. The appointment of an MLA had impact on 
practice by improving the return rate of labels and also investigating what had 
happened to blood units with missing labels. The appointment of an MLA met the 
need highlighted in the study by: 
 Improving traceability of labels after the completion of the transfusion. 
 Encouraging frontline staff to call the laboratory when labels were 
misplaced or destroyed. 
 Identifying areas of poor traceability compliance within the Trust as a 
stimulus for more training. 
 Minimising potential problems in the surgical setting where there was 
previously low compliance. 
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5.1.5  Air tube system 
The air tube system installed at the Trust alleviated the pressure of returning the 
labels from transfused products to the laboratory promptly. The system has also 
changed and improved the rate of return to the pathology laboratory. The return of 
the labels enables the transfusion department to track the destination of the unit 
and update the system within 4-8 hours following the transfusion. Annual skills 
check  
Clinical governance introduced systems for continuing professional development 
(Department of Health, 1997). These systems are monitored and linked to 
registration, peer assessment, evidence-based standards of care and individual 
appraisal (Barr, 2000, p.81). Clinical governance is concerned with the ways in 
which the National Health Service can improve and maintain the quality of care and 
services provided for patients (Scally & Donaldson, 1998, p.61). National 
Occupation Standards were developed to raise the standard of practice in a given 
sector and providing a benchmark against which the performance of both the 
individual and the organization could be assessed and measured. These standards 
provide a systematic approach to the establishment of good practice, supported by 
a clear framework of underpinning knowledge, standards and expected outcomes 
(National Institute for Mental Health in England, 2003, p.3, 5). 
 
 
5.2 Cost-benefit analysis 
There has been a drop in annual blood wastage within the Trust from 290 units in 
2006 to 100 units in 2011. The benefit of these savings amounted to £67,790 over 
the five year period within the Trust. The cost of for the full implementation was not 
evaluated in this study. The average cost of a full tracking system in a medium size 
hospital was valued at £350,000 excluding training and staffing during our lunch 
time presentation by vendors. The main area of cost impact were the appointment 
of a transfusion practitioner, a medical laboratory assistant and installation of the 
air-tube system within Trust. Porters were not needed to carry out deliveries, the 
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reduction in manpower was also a big savings to the Trust and there was an 
improved of turnaround times in labels deliveries.   
Table 5-1 Reduction in red blood cell wastage 2006-2011 
Month 2011 2010 2009 2008 2007 2006 
January 5 9 24 12 10 28 
February 4 5 9 15 31 7 
March 4 4 10 18 5 39 
April 8 11 30 11 7 6 
May 6 6 9 5 4 11 
June 8 10 18 7 25 10 
July 12 8 32 10 15 9 
August 6 15 15 30 15 55 
September 10 18 14 10 13 8 
October 20 39 22 40 5 20 
November 13 17 12 22 25 10 
December 4 5 24 20 110 6 
Total 100 147 215 200 265 290 
Cost £13,000 £19,110 £27,950 £26,000 £34,450 £37,700 
5.3 Email questionnaire 
The duration of the project prompted a follow-up questionnaire to identify any gaps 
and capture the current trends in traceability compliance. An email-based survey 
was chosen to reduce the time and resources involved in individual interviews and 
to eliminate travel requirements. 
5.3.1 Method 
Participants were purposively selected from NHS Trust hospitals in the North East 
of London. The twenty respondents were blood bank managers. Participants were 
asked closed questions on individual Trust traceability compliance. The responses 
to the various questions were coded. As before, data was entered into a 
spreadsheet and analysed using SPSS software (SPSS, 2010). The data 
generated was coded to enable a numerical analysis. The data was not normally 
distributed,  
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Table 5-2 Demographics of the NHS Trusts surveyed. 
 Frequency (n=20) % 
Bed capacity   
1–500 6 (30) 
501–1,000 13 (65) 
> 1,000 1 (5) 
Trusts with satellite fridges  
Yes 16 (80) 
No 4 (20) 
Transferring blood to other sites  
Yes 16 (80) 
No 4 (20) 
Tracking system in place  
Paper tracking 14 (80) 
Electronic tracking 6 (20) 
Cost of tracking system in place  
Medical laboratory assistant 13 (65) 
Not known 7 (35) 
Hospital staff trained in the collection of blood  
0–25% 1 (5) 
26–50% 6 (30) 
51–75% 2 (10) 
76–100% 11 (55) 
Red cell units transfused in the last 12 months  
> 5,000 16 (80) 
< 5,000 3 (15) 
Unknown 1 (5) 
Average traceability compliance  
< 75% 1 (5) 
> 75% 19 (95) 
User feedback mechanism  
Yes 15 (75) 
No 5 (25) 
Audit of the transfusion process  
Yes 16 (80) 
No 4 (20) 
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5.3.2 Results  
Table 5-2 showed that out of 30 emails sent to blood bank managers, 20 
responses (66%) were acknowledged. The results obtained were similar to my 
previous study on page 71. There was a positive correlation between transfusion 
and traceability compliance (r = 0.59; p = 0.01) and training but with no significant 
difference (r = 0.30; p = 0.38). 
5.4 Summary 
The findings from the study reiterated that the importance of continuous 
professional development and skills assessments cannot be overemphasized, 
effective training at ward level improved traceability compliance.  
The findings from this study also reiterated the importance of a trained specialist 
transfusion nurse who can provide support and training to frontline personnel 
involved in the collection and transfusion of blood products. Their role is also to 
ensure that training and the delivery of healthcare meet acceptable standards. The 
research highlighted the importance of training and continuing professional 
development. Wards where there are trainers provide a higher standard of care 
than wards without a trainer.  
I also found out that wards that carried out many transfusions performed better 
than those that only carried out a few. This information enabled enhanced training 
to be provided in the poorly performing units.  
The project provided an insight into the variety of services delivered to the end-
users of transfusion services. It highlighted a lack of training tools; poor procedures 
for the return of labels and the unreliability of porters. Poor communication between 
the laboratory and end-users was identified as another issue. The response to 
these problems led to the innovative use of the air tube system and greater incident 
reporting at every stage of the transfusion process.  
The initial survey provided a baseline from the problems that can be encountered 
at the blood collection point and in the bedside checking procedure. The issues that 
were identified included incomplete documentation brought to the blood collection 
point and untrained personnel collecting blood products at the blood collection 
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point. The problem of blood product collection was addressed by providing security 
locks on the blood fridges to deter untrained staff collecting blood products, In 
greater number of cases this had been effective. It has become mandatory that two 
nurses must check blood products administered on the wards. 
It became evident that traceability compliance varied from one Trust to the other 
and various strategies were being deployed to attain full compliance. Technology 
has been introduced by many Trusts, but in this case there was neither the time nor 
the money to investigate it fully. This may not be so much of a problem; the study 
by Murphy et al. (2004) observed that most tracking systems could be overridden 
and concluded that such systems could only assist in reducing errors. Arinsburg et 
al.,(2011) also concluded from their study that additional training in transfusion 
medicine would be beneficial by physicians in all specialities. This was based on 
their findings from the survey conducted which demonstrated lack of knowledge of 
transfusion medicine across all specialities and all training levels. 
It was also evident that previous studies had only focused on blood product 
traceability and not on the direct or indirect variables that affected traceability e.g. 
ward size, transfusion times, training, traceability methods, transfusion volume, 
emergency situations, training and errors in the transfusion chain. The full impact of 
traceability will only become clear when more rigorous, large-scale studies are 
conducted that take into consideration all possible variables. 
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6 Reflection 
My enrolment onto the professional doctorate has been an attempt to advance the 
scope of my practice and become a competent professional. I have found the 
professional doctorate to be both challenging and rewarding. The course has 
improved how I think about different situations and how I function as an advanced 
practitioner. 
According to Honey and Munford (1992) I was exposed to new experiences 
compared to my prior learning. The professional doctorate influenced me to adopt a 
new learning style as an activist and a reflective thinker. Active learning engages 
students in class activities was encouraged and cooperative learning (working in 
small group teams under conditions that hold all team members accountable for the 
learning objective associated with the assignment (Felder and Brent, 2003, pp.282-
283). 
 The curriculum was well-structured and related to my employment. There were 
opportunities to ask questions and read extensively in order to confirm any unclear 
evidence which I have missed during my previous learning. 
Berhold et al. (2000, p.191) described two groups of students, one taught in a circle 
and the other taught with tradition methods. The course grade of the two groups 
were compared and indicated that the traditionally taught students were more likely 
to get lower grades than the students taught in a circle. They concluded that holistic 
instruction may help a more diverse group to succeed. According to Kolb (1993, 
pp.3-4), learning begins with a concrete experience; the effect is reflective 
observation, documenting what happened and making sense, then investigating or 
theorizing. This allows conclusions to be drawn and plans to be made in order to 
take further action based on the experience. 
Felder and Brent (2004, p.269) proposed five instructional conditions that provide a 
balance of challenge and need to promote intellectual growth: 
 Variety and choice of learning tasks. 
 Explicit communication and explanation of expectation. 
 Modelling, practice and constructive feedback. 
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 A centred instructional environment. 
 Aware of current levels of development. 
 
Figure 6-1 Kolb’s learning cycle, adapted from Kolb and Fry, 1975 
Kolb and Fry (1975, pp.35-36) argued that the learning cycle can begin at any of 
the four points and should be approached as a continuous spiral. In this context, I 
was able to reflect on my previous employment about wastage of resources within 
the transfusion department. 
Bloom (1956, p.6) ranked learning into categories of knowledge e.g. ability to recall 
from memory to the most sophisticated and complex evaluations of making critical 
judgement. It is clear to me that the learning methods employed within the 
professional doctorate were designed to guide me to an advance stage of acquiring 
and understanding. The theoretical application in the real world encouraged me to 
decide on an issue and make critical judgments when planning to undertake any 
research for the department. This process also reinforces the importance of Kolb 
learning cycle. 
The professional doctorate at the University of Portsmouth comprises two parts. 
Part one was the taught element that covered professional review and 
development, advance research techniques and publication and dissemination. 
Part two consisted of the project proposal and the research thesis. 
Abstract 
conceptualization (3) 
Active 
Experimentation 
Observation and 
reflection (2) 
Concrete 
Experience (1) 
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I was motivated throughout the course to learn new skills in research methodology, 
which I have overlooked in the past. The qualitative analysis was a challenge that 
was completely new to me, which I later found useful. It became obvious that I 
needed to focus more to understand this aspect. Aspects were the publication and 
dissemination module, and research and development that I found more relevant 
in. I have put this process into practice in decision-making as well as the 
modification of the training programme for Biomedical Scientist undertaking 
professional portfolio examination in Biomedical Sciences. 
Part two of the course entailed completing an innovative research project that can 
also help in providing data in support of evidence-based information in blood 
transfusion.  
I was excited to start this thesis that aimed to implement and evaluate blood 
product traceability procedures at the Homerton University Hospital NHS Trust. In 
the initial stages, it was clear that coordination was a problem because of a lack of 
funding to implement a tracking system and the lack of support from management. 
Most of the activities aimed at achieving good traceability compliance were carried 
out behind closed doors and a lot of phone calls were made in order to follow up on 
poor compliance within the Trust. This meant that there was a heavy workload for 
myself and junior staff in the department and a steep learning curve. The project 
entailed big changes within the Trust which I overlooked in the early stages.  While 
not stopping to think before taking action can produce spectacular results, I can 
recall that on many occasions I made things worse by blaming frontline staff and 
raising incident reports. Although this is normal procedure it did not resolve the 
problem of poor compliance. This happened because I failed to stop and think 
before trying to changes things. Later, I realised that I had to take a broader, 
educational approach to deal with the situation and frontline staff.  
The visit by the Medicines and Healthcare products Regulatory Agency (MHRA) at 
an early stage of my project resulted in a change in direction concerning how 
traceability was perceived by frontline staff. The visit reinforced the importance of 
achieving full compliance, particularly as the Trust‟s management including the 
Chief Executive were present to hear the MHRA‟s summary of the inspection. This 
showed that traceability compliance was poor and that there were no structures in 
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place or indications that the Trust was addressing the situation. This gave my work 
fresh impetus and management then took a lot of interest in my area of study. 
I realised that I must take time to review the situation and consider theoretical 
aspects prior to commencing any work.  I was aware of the risk that I might lose 
focus when working on such a large project, but I have a good record of bringing 
tasks to completion. I believe that I have achieved success when I have 
unconsciously taken the approach of breaking the task down into smaller bits, and 
approaching the problem logically. I now appreciate that this approach includes 
reflection as it creates natural breaks where I have been able to reflect upon what 
has been done and plan  what remains to be done; this has contributed to my 
success.  
The Trust‟s Chief Executive became involved when a message was sent to all staff 
members saying that the collection, handling and usage of blood products was an 
area of great concern. I realised at this stage that a few senior clinicians had opted 
out, but the majority of frontline staff members were happy to be trained and 
assessed. 
In 2008, I was nominated by my professional body, the IBMS, and became an 
assessor for Specialist Portfolios in Haematology and Blood Transfusion. This 
means that I must provide reports against pre-defined standards, and made me 
pay further attention to quality issues in blood transfusion; I compared information 
from visits and developed a framework for my thesis as the study progressed. 
Although my project has finally ended, the importance of clinical and non-clinical 
personnel in the transfusion chain cannot be overemphasized. It was difficult to 
coordinate and pass instructions to frontline staff at every stage of the study. These 
issues were eventually overcome by asking the transfusion practitioner to feedback 
any problems as soon as they occurred.  During the project, it was necessary for 
me to encourage open thinking. 
I do feel that I have benefited from the course, even though it took me a while to 
prepare the research proposal. The principles underpinning the whole study were 
learnt throughout the course. I feel now that I can conduct and develop a research 
method using the advanced research skills and the professional knowledge that I 
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have in my specialist area. I also fully understand the skills necessary to publish 
rigorous clinical research. 
I spent the early part of the course to learning critical reflection practices and 
putting these into practice by reflecting on my own needs and learning styles. This 
also helped in all the modules of the professional doctorate and find ways to better 
understand what I was learning. The idea for my professional doctorate was initially 
conceived through my reflective practices and I decided to write few publications on 
these areas in my professional journal, the IBMS gazette. 
I have taken the technique of reflection back to my clinical practice in order to 
evaluate all the procedures we follow. My colleagues knew there would have to be 
changes within the section. We set aside time for to investigate and reflect upon 
incidents. We developed a habit of responding as fast as possible to incidents and 
enquiries and since I started the professional doctorate the service within the Trust 
has changed. 
The research has been daunting. It has required me to rally a multidisciplinary task 
force within the Trust for data collection and analysis. I had to get the complete 
support of staff and the Trust for the study to succeed. 
I found the data analysis very difficult, but interesting. It required coding and 
rechecking for missing figures. The module I took on data analysis using SPSS 
was useful and this was followed by months of writing up. I would like to commend 
the patience of staff members; although many had little time, they listened and 
participated in the study. 
The literature review during the study, highlighted incidents in the early days of 
blood and the advancement in blood, problems with blood safety, innovation 
achieved in the collection, testing, distribution and traceability of blood products. 
The human error in the handling and the use of blood and its products remains a 
challenge in the 21st century. My thesis, identified that there was lack of knowledge 
and training of personnel  in the handling and the use of blood within the Trust 
which led to .    
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6.1 Developing the extending role 
Achieving traceability compliance within the Trust had been a painful and complex 
process. I had to engage with all staff in the Trust in order to highlight the 
importance of full traceability. The Trust management were very helpful in providing 
their time and expertise. That the project has succeeded clearly demonstrates that 
biomedical scientists can interact with other Trust professionals and extend their 
role beyond the laboratory using their knowledge to provide diverse health service 
models.  
6.2 Future goals 
The professional doctorate considerably contributed to my self-development and 
management skills. I am confident in discussing research with my colleagues. My 
role as the transfusion lead has led to increased exposure at a more senior level 
allowing further development of my career.  
My goal is to use my rich experience in clinical research to teach, and develop 
protocols and guidelines within the profession. Specifically, to influence practice 
through meetings, special interest group and disseminating information. I am also 
keenly looking forward to helping others to develop and maximize their skills in 
laboratory medicine. The achievement of the doctorate will help me to progress 
towards the post of consultant biomedical scientist. 
6.3 Dissemination  
A requirement of the doctorate is to ensure dissemination of the data and the 
outcome of the project; this has been achieved through various means both locally 
and nationally. 
Locally, I made audits presentations at lunchtime meetings to health personnel in 
the Trust. Information was disseminated to wards with poor compliance levels in 
writing during the implementation stages. Furthermore, I developed feedback on 
the clinical effectiveness of the model, this was needed in order to assess its 
success and determine any modifications required to improve full traceability 
compliance. 
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Nationally, the findings of the project and the implementation of new compliance 
measures have been disseminated through poster presentations and lectures at 
meetings, including the Biomedical Sciences Congress (2011) in Birmingham and 
the British Blood Transfusion Conference (2012) in Harrogate. A poster 
presentation was also given at the American Medical Technology International 
Conference (2011) in the United States.  
The major learning outcome from the dissemination of my work was the ability to 
communicate information in a clear and precise manner, particularly the ability to 
communicate with the audience during poster presentations and hear their 
feedback.  
 108 
 
7 References  
Abdulrazzak, R., Al-Muharib, S., Dashty, R. et al. (2009). Traceability of red cells 
components. A two stage audit on the accuracy of traceability records in Kuwait 
Central Blood Bank and two small hospitals blood banks. Vox Sanguinis, 96, 208. 
Aller, R. (2005). Positive patient identification: more than a double check. CAP 
today, 26–34. 
Andreu, G., Morel, P. and Forestier, F. (2002). Haemovigilance Network in France. 
Transfusion, 42: 1356-1364. 
Arinsburgh, S., Skerrett, D., Friedman, M., Cushing, M. (2012). A survey to assess 
transfusion medicine education needs for clinicians, Transfusion Medicine, 22:44-
51. 
Asamoah, A. (2006). Not as easy as it appears: Using radiofrequency identification 
technology. Food Drug Law Journal, 2, 385–418. 
Ashbourn, J. (2004). Where we really are with biometrics. Biometric Technology 
Today, 12(4), 7–9. 
Ashford, P. (2006). ISBT 128 – improving security by international standardization. 
ISBT Science Series, 1(1), 242–245. 
Askeland, R. W., McGrane, S., Levitt, J. S., Dane, S. K., Greene, D. L., Vandeberg, 
J. A., Walker, K., …Kemp, J. D. (2008). Improving transfusion safety: 
implementation of a comprehensive computerized bar code-based tracking system 
for detecting and preventing errors. Transfusion, 48 (7), 1308–17.  
AuBuchon, J. (2006). How I minimise mistransfusion risk in my hospital. 
Transfusion, 46, 1085–1089.  
AuBuchon, J. and Litternberg, B. (1996). A cost effectiveness analysis of the use of 
a mechanical barrier system to reduce the risk of mistransfusion. Transfusion, 36, 
222–226.  
 109 
 
Bachs, A., Aliu, G., Gmez, I., Orfila, R. and Mingo, T. (2009). Balance after 
implementing a new transfusion safety system: A 2 year experience. Transfusion 
Medicine, 20, 1295.  
Baele, P., De Bruyere, M., Deney, V. and Dupont, E. (1994). Bedside transfusion 
errors. A prospective study by Belgium Sanguins group. Vox Sanguinis, 66, 119–
121. 
Baldwin, P. (2005). Disease and Democracy. The Industrialised World Faces AIDS. 
Berkeley. 
Ballard. S., J., Liewelyn, C., Murphy, M. and Williamson, L. (2002). Tracing blood 
units to their recipients: results of a two-centre study. Transfusion Medicine, 13, 
127–130. 
Battle, J., Kaplan, H., Van der schaaf, T. and Shea, C. (1998). The attributes of 
medical events-reporting system for transfusion medicine. Archives of Pathology & 
Laboratory Medicine, 122, 231–238. 
Barr, H. (2000) NHS new collaboration, New agenda for Education. Journal of 
Interprofessional Care, 14 (1), 81–6. 
Berhold, L., Bingham, W., McDonald, P. and Atta, M. (2000). Impact of Holistic and 
Learning-Oriented Teaching on Academic Success. Journal of Engineering 
Education, 89(2), 191–99. 
Bennardello, F., Fidone, C., Cabibbo, S., Calabrese, S., ... Bonomo, P. (2009). Use 
of an identification system based on biometric data for patients requiring 
transfusion guarantees transfusion safety and traceability. Blood Transfusion, 
7,193–203. 
Berwick, D. (1989). Continuous improvement as an ideal in health care. New 
England Journal of Medicine, 32, 53–56. 
Blood Safety and Quality Regulations (2005). The Stationery Office Ltd, London.  
Bloom, B. (1956). Taxonomy of Education objectives. New York: David Mckay and 
Co. 
 110 
 
Burnes, B. (1996). Managing Change: A Strategic Approach to Organisational 
Dynamics.  
Busch, M. (1991). Let's look at human immunodeficiency virus look-back before 
leaping into hepatitis C virus look-back. Transfusion, 31, 655. 
Busch, M., Chamberland, M., Epstein, J., Kleinman, S., Khabbaz, R. and Nemo, G. 
(1999). Oversight and monitoring of blood safety in the United States. Vox 
Sanguinis, 77, 67–76.  
Chaffe, B., Jones, J., Milkins, C., Taylor, C., Asher, D., Glencross, H., Murphy, M. 
and Cohen, H (2009). UK Transfusion Laboratory Collaborative Recommended 
minimum standard of hospital transfusion laboratories. Transfusion Medicine, 19, 
156–158. 
Chambers, R., Rubin, M., Rath, C., Sandler, S. and Ball, J. (1973). A positive donor 
recipient identification system for a regional blood transfusion service. Transfusion, 
13, 34–6.  
Chan, J., Chu, R., Young, B., Chan, F., Chow, C., Pang, W., Chan, C., Yeung S., 
Leung, P. (2004). Use of an electronic barcode system for patient identification 
during blood transfusion: 3 year experience in a regional hospital. Hong Kong 
Medical Journal, 10,166-71.  
Classen, D., Stanley, M.D., Pestonik, S., Evans, R. and Burke, J. (1991). 
Computerized surveillance of adverse drug events in hospital patients. JAMA, 266, 
2847–2851.  
Cook, R., Wood, D. and Miller, C. (1998). A tale of two stories: contrasting views of 
patient safety. US National Patient Safety Foundation, MA. Retrieved from 
http://www.npsf.org/exec/front.html.  
Council of Europe (2003). Guide to the preparation use and quality assurance of 
blood component. Recommendation No. R(95)15. Ninth Edition. Strasbourg. 
Currie, L. (2003). Clinical Governance: An RCN resource guide. Retrieved from 
www.ntac.nhs.uk/web/files. 
 111 
 
Curtain, L. (1997). When negligence becomes homicide. Nursing Management, 2, 
7-8. 
Dalton, J., Poncet, I., Rossini, S. (2005). "Using RFID technologies to reduce 
transfusion errors. Retrieved from http://www.cisco.com/global/IT/local_office/case_ 
History/rfid_in_blood_transfusion_final.pdf 
Davies, J., Kay, J., Casbard, A. and Murphy, M. (2006). End to end electronic 
control of the hospital transfusion process to increase the safety of blood 
transfusion: Strengths and weaknesses. Transfusion, 46, 352-364. 
Davis, R., Geiger, B., Gutierrez, A., Heaser,J. and Veeramani, D. (2009). Tracking 
blood products in blood centres using radio frequency identification: a 
comprehensive assessment. Vox Sanguinis, 97, 50–60. 
de Vries, P., Faber, C. and Strengers, W. (2011). Haemovigilance: an effective tool 
for improving transfusion. Vox Sanguinis, 100, 60–67. 
Debeir, J., Noel, L., Aullen, J., Frette, C., Sar,i F., Mai, M.P. and Cosson, A. (1999). 
The French Haemovigilance System. Vox Sanguinis, 2, 77–81. 
Department of Health. (1997). The New NHS: modern, dependable. London: 
HMSO. 
Department of Health (1998). A first class service. Quality in the new NHS. London: 
HMSO. 
Department of Health (1998a). Better Blood Transfusion. Health Service Circular 
1998/224. 
Department of Health. (2003) Developing NHS Direct: a strategy document for the 
next three years. London: HMSO 
Department of Health. (2004). Pathology Modernisation., London: HMSO 
Dodd, R. (2006). Other emerging viral pathogens. ISBT Science Series, 1(1), 257–
262. 
 112 
 
Doughty, H. and Hitchinson, M. (2010). A tale of traceability. Transfusion Medicine, 
20, 53. 
Dzik, W. (2002). Transfusion safety in hospital. Transfusion, 43, 1190–1198. 
Dzik, W. (2003) Emily Cooley Lecture 2002: transfusion safety in the hospital, 
Transfusion, 43, 1190–1199. 
Dzik, W. (2005) Technology for enhanced transfusion safety. American Society of 
Hematology, Education Program, 476-82. 
Dzik, W. (2006). New technology for transfusion safety. British Journal of 
Hematology, 136, 181-190. 
Embrey, D. (1992). Quantitative and qualitative prediction of human error in safety 
assessment. Institute of chemical Engineering. Rugby. 
Engelfriet, C. and Reesink, H. (2000). Bacterial contamination of blood 
components. Vox Sanguinis, 78, 59-67. 
European Union Directive 2002/98/EC. Retrieved from http://www.europa.e.int. 
Evans, P. (2000) Management 21st Century: Someday we will all manage this way. 
Chowdbury Financial Times. Prentice Hall, London. 
Faber, J. (2002). Haemovigilance around the world. Vox Sanguinis, 1, 71-76. 
Faber, J. (2004). The European Blood Directive: a new era of blood regulation has 
begun. Transfusion Medicine, 14, 257-273. 
Fanberg, H. (2004). The RFID revolution. Marketing Health Services. Fall 24, 22-4. 
Farrugia, A. (2006). Globalization and blood safety. ISBT Science Series, 1(1), 25-
32. 
Feldman, E. and Bayer, R. (1999). Blood Feud: AIDS, Blood and the politics of 
Medical Disaster. New York: Oxford University Press. 
 113 
 
Felder, M. and Brent, R. (2003) Learning by doing. Chemical Engineering 
Education, 37(4) 282-3. 
Felder, M. and Brent, R. (2004). The intellectual development of Sciences and 
Engineering Student. Models and Challenges. Journal of Engineering Education, 
93(4), 279-91. 
Fisher W.(2004) The role of WIPO in addressing the health crisis in developing 
countries. Retrieved from www.tacd.org/events/wipo/w_fisher.ppt. 
Fisher W. (2004). The role of WIPO in addressing the health crisis in developing 
countries. Retrieved from http://www.tacd.org/events/wipo/w_fisher.ppt.  
Gallo, R. and Montagnier, L. (2003). The discovery of HIV as a case of AIDS, New 
England Journal of Medicine, 349, 2283-2285. 
Gambino, R. and Mallon, P. (1991). Near Misses: an untapped database to find 
root causes. Lab report, 13, 41-44. 
General Medical Council (2011). Good Medical Practise Framework for appraisal 
and revalidation, London. Retrieved from www.gmc-uk.org/doctors/revalidation/asp. 
Glynn, S., Busch, M., Schreiber, G. and Murphy, E. (2003). Effect of a national 
disaster on blood supply and safety. JAMA, 17, 2246-2253. 
Goodnough, L. and Spence, R. (2003). Bloodless medicine: clinical care without 
allogeneic blood transfusion. Transfusion, 43, 668-676. 
Goldman, M., Long, A., Roy, G., Decary, F. and Delage, G. (1996). Incidence of 
bacterial cultures after donor call back. Transfusion, 36 (11-12), 1035. 
Hammadi, A. (2009). The haemovigilance in Saida hospital - A prospective study. 
ISBT Science series, 217. 
Hay, S., Scanga, L. and Brecher, M.E. (2006). Life, death, and the risk of 
transfusion: A University hospital experience. Transfusion, 46 (9), 1491-1493. 
Health Professions Council (2004). HPC Standards of proficiency – Biomedical 
Scientist. Retrieved from: http://www.hpc-uk.org/publications/index.asp?id=40. 
 114 
 
Health Protection Agency Report (2011). Surveillance of viral infection in donated 
blood  ( England and Wales). Annual report 2011. 
Herve, P. (2002). Haemovigilance network in France: organisation and analysis of 
immediate transfusion incident report from 1994 to 1998. Transfusion, 42, 1356-
1364. 
Herve, P., Rebibo, M., More, P. and Andreu, G. (2000). Haemovigilance in France. 
Rev Bras Hematol.Hemoter, 22(3), 368-373. 
Hollnagel, E. (1998). Cognitive reliability and error analysis method. Elsevier, 
Oxford. 
Honey, P. and Munford, A. (1992). The Manual of Learning Styles. Ardingly House, 
Maidenhead: Peter Honey. 
Hopkins, S. (2005). Advance in patient and specimen ID. Advance New Magazine, 
2:13. 
Ingrand, P., Salmi, R., Benz-Lemoine, E. and Dupuis, M. (1998). Evaluation of the 
actual traceability of labile blood products using medical records. Transactions of 
Clinical Biology, 6, 397-407. 
Jury, G. (1997). Managing Technology. Engineering Management Journal, 7, 27-
32. 
Kaplan, H., Battles, J. and Van der Schaaf, T, Shea, C.E. and Mercer, S.Q. (1998). 
Identification and classification of the causes of events in blood transfusion 
medicine. Transfusion, 38, 1071-1081. 
Kaplan, H. (2005). Getting the right blood to the right patient: The contribution of 
near miss events reporting and barrier analysis. Transfusion Clinique et Biologique, 
12, 380-384. 
Kennedy, I. (2001). The report of the public inquiry into children's heart surgery at 
the Bristol Royal Infirmary 1984–1995. 
 115 
 
Kimball, A., Arima, Y. and Hodges, J. (2005). Trade related infection: farther, faster, 
quieter. Globalisation and Health, 1, 1–6. 
Kleinman, S. (1991). Donor screening procedures and their role in enhancing 
transfusion safety. American Society of Clinical Pathologists, p.207. 
Kolb, D. and Fry, R. (1975). Toward an applied theory of experiential learning. In  
C.L. Cooper (ed.), Theories of group processes (33-57). Chichester: Wiley & Sons. 
Kohn, L., Corrigan, J. and Donaldson, M. (1999). To err is human: building a safer 
health system. National Academy Press, Washington, DC. 
Kolb, D. (1993). The process of experiential learning. Culture and processes of 
adult learning. London: Routledge. 
Kreil, T., Berting, A., Kisnter, O. and Kindermann, J. (2003). West Nile virus and 
safety of plasma derivatives. Transfusion, 438, 1023–1028. 
Kubler-Ross, E. (1969). On Death and Dying. Macmillan, New York. 
Lau, F., Wong, R., Chui, C., Ng, E. and Cheng, G. (2000). Improvement in 
transfusion safety using a special design transfusion wristband. Transfusion 
Medicine, 1, 121-124. 
Lewin, K. (1951). Field Theory in Social Sciences, Harper and Row, New York. 
Linden, J., Wagner, K., Voytovich, A.E. and Sheehan, J. (2000). Transfusion errors 
in New York State: an analysis of 10 years' experience. Transfusion, 40 (10), 
1207–1213. 
Ling, A. (2010). Failure of routine HIV test in a case involving transfusion of 
seroconversion blood components during the infection window period. Journal of 
American Medical Association, 284, 210-14. 
Lovis, C. (2008). Traceability in Healthcare: Crossing Boundaries. Yearbook of 
Medical Informatics 1998, 105–113. 
 116 
 
Marconi, M. and Sirchia, G. (2000). Increasing transfusion safety by reducing 
humam error. Current Opinion in Haematology, 7, 382-386. 
Mathur et al., (2006) Compliance of West of Scotland Bolld Centre Audit of Hospital 
Compliance with Traceability. Transfusion Medicine, 16:22 
Mattar, M. (2004). Blood and you. Health and Science Alternative Medicine. 
McClelland, B., McMenamin, J., Moore, M. and Barbara, J. (1996). Reducing risks 
in blood transfusion. Transfusion Medicine, 6(1), 1-10. 
McClelland, B., Love, E., Scott, S., & Williamson, M.(1998). Haemovigilance: 
concept, Europe and UK initiative. Vox Sanguinis 74,431-439.  
Mercurialli, E., Inghilleri, G., Colotti, M., Fare, M., Vinci, A., Podico, M. & 
Scalamogna, R. (1996). Bedside transfusion errors: Analysis of two years use of a 
system to monitor and prevent transfusion errors. Vox Sanguinis, 70, 16-20. 
Mummert, E. and Tourault, M. (1993). Review of transfusion related fatalities: many 
preventable. Hospital Technology Scanner, 4, 1-3. 
Murff, H., Patel, V., Hripcsak, G., Bates, D. (2003) Detecting adverse events for 
patient safety research: a review of current methodologies. Journal of Biomedical 
Informatics, 36, 131-143. 
Murphy,M. and Kay, J. (2004) Barcode identification for transfusion safety. Current 
Opinion in Haematology, 5, 334-38. 
Murphy, M., Stanworth, J. and Yazer, M. (2011). Transfusion practise and safety: 
current status. Vox Sanguinis, 100, 46–59. 
Murphy, M., Lowe, D. and Pearson, M (2001). National audit of the blood 
transfusion process in the U.K. Transfusion Medicine, 11, 363-370. 
Nagel, C. (1988). Human error in aviation operation. Academic Press, San Diego. 
National Patient Safety Agency (2004) Incident Decision tree. Online retrieved from 
http://www.npsa.nhs.uk. 
 117 
 
National Patient Safety Agency (2005). Improving patient safety through better 
manual and technology based system for identification and matching of patients 
with care. Retrieved from http://www.npsa.nhs.uk. 
National Patient Safety Agency (2006). Safer practice notice: Right Patient, Right 
Blood. London NPSA. 
Nevalainen D., Berte, L. and Callery, M. (1998). Quality system in blood bank 
environment. Second edition. Bethesda,MD: American Association of Blood Banks. 
Nevalainen D. and Lloyd, H. (1995). ISO 9000 quality standards: a model for blood 
banking?. Transfusion, 35, 521-24. 
Norfolk, D. (2000). Experience with electronic system control in clinical transfusion 
process. SHOT Annual report. 
Nichols, J., Bartholomew, C., Brunton, M., Clintron, C. Elliott, S., McGirr, J., Morsi, 
D., Sinha, D. (2004). Reducing medical errors through barcoding at the point of 
care. Clinical Leadership Management Review, 18, 328-34. 
National Audit Office (2006). Progress in implementing Clinical Governance in 
Primary Care Trust. Stationary Office. 
National Institute for Mental Health in England (2003). National Occupational 
Standard Implementation Guide. UK. 
Novis, D., Miller, K., Howanitz, P., Renner, S. and Walsh, M. (2003). Audit of 
transfusion procedures in 660 hospitals. Transfusion Medical Review, 17, 169-180. 
Nursing and Midwifery Council. (2009) Code of professional conduct. London: 
NMC. 
Orlikowski, W.J. and Hoffman, J.D. (1997). An improvisational model for Change 
Management: The Case of Groupware Technologies. Sloane Management Review, 
11–21. 
Oxman, A., Thomas, M., Davis, D. and Hayes, R. (1995). No magic bullets: a 
systematic review of 102 trials of interventions to help health professionals deliver 
 118 
 
services more effectively and efficiently. Canadian Medical Association Journal, 
153,1423-31. 
Pagliaro, P. and Rebulla, P. (2006). Transfusion recipient identification. Vox 
Sanguinis, 91, 97-101. 
Pagliaro, P. and Turdo, R. (2008). Transfusion management using a remote-
controlled automated blood storage. Blood Transfusion, 6, 101-106. 
Perper, J. (1994). Life-threatening and fatal therapeutic misadventures. In Bogner, 
M.S., Ed., Human Error in Medicine. Hillsdale, NJ. 
Peters, T. (1989). Thriving on Chaos. Macmillan Ltd, London. 
Rasmussen, J. (1987). The definition of human error and a taxonomy of technical 
system design.London: John Wiley & Sons LTD. 
Reason, J. (1990). Human Error. Cambridge University Press, New-York. 
Reason, J. (2001). Understanding adverse events: the human factor. In: Vincent C 
(ed).  
Robillard, P., Chan, P. and Kleimann, S. (2004). Haemovigilance for improvement 
of blood safety. Transfusion Apheresis, 31, 95-98. 
Salmi, L., Azanowsky, J. and Perez, P. (1997). Haemovigilance in France: Where 
we stand in 1985. Proceedings of the ISBT-Ed, 964-974. 
Sandler, S., Langeberg, A. and Dohnalek, I. (2005). Bar code technology improves 
positive identification and transfusion safety. Developments in Biologicals, 120, 19-
24. 
Satir, V., Banmen, J., Gerber, J. and Gomori, M. (1991). The Satir Model: Family 
therapy and beyond. 
Sazama, K. (1990). Reports of 355 transfusion associated deaths 1976-1985. 
Transfusion, 7, 583-590. 
 119 
 
Scally, G. and Donaldson, L. (1998). Clinical governance and the drive for quality 
improvement in the new NHS in England. British Medical Journal, 317, 61-65. 
Schreiber, G., Busch, M., Kleinman, S. and Korelitz, J.J. (1996). The risk of 
transfusion transmitted viral infection: The Retrovirus epidemiology donor study. 
The New England Journal of Medicine, 334, 1685-1690. 
Schulman, P. (2004). General Attributes of safe Organisation. Quality and Safety In 
Healthcare, 13, 39-44. 
Sellu, D., Davis, R., Vincent, A. (2012). Assessment of blood administration 
competencies using objective structured clinical examination. Transfusion 
Medicine, 22: 409-417. 
Serious Hazards of Transfusion (2001-2011) SHOT Reports and summaries. 
Retrieved from http://www.shot-uk.org. 
Serious Hazards of Transfusion (2011). Serious Hazards of Transfusion Annual 
Report 2011. SHOT Office, Manchester, UK 
Serious Hazards of Transfusion (2009). Serious Hazards of Transfusion Annual 
Report 2009. SHOT Office, Manchester, UK 
Sherer, P., Chambers, H., Taswell, C., Altshuler, R., Aster, K., Covino, S., Gordon, 
M., Gajewski, A., Smith, S., Horrigan, K., & Pfatt, K. (1977). Automated Donor-
Recipient Identification Systems as a mean of reducing human error in blood 
transfusion. Transfusion, 17, 586-597. 
Shulman, I., Saxena, S. and Ramer, L. (1999). Assessing blood administering 
practices. Archives of Pathology & Laboratory Medicine, 123, 595-598. 
Snyder, E. and Dodd, R. (2001). Reducing the risk of blood transfusion. 
Haematology, 433-442. 
SPSS Inc (2010) SPSS Version 19.0 for Windows user guide. SPSS Inc, Chicago, 
IL. 
 120 
 
Stainsby, D. (2005). ABO incompatible transfusion experience from the UK Serious 
Hazard of Transfusion scheme. Transfusion, 12, 380-384. 
Starr, D. (2001).Medicine, money, and myth: an epic history of blood. Transfusion 
Medicine, 11(2), 119-121. 
Steinbrook, R. (2002). Nursing in the crossfire. New England Journal of Medicine, 
346, 1757-1766. 
Taswell, H., Smith, A., Sweatt, M. and Pfaff, K. (1974). Quality control in blood 
bank: a new approach. American Journal of Clinical Pathology, 62, 491-495. 
Toeffler, A. (1983). Future shock. Bodley Head. 
Turner, C., Casbard, A.C. and Murphy, M.F. (2003). Barcode technology: its role in 
increasing the safety of blood transfusion. Transfusion, 43, 1200-1209. 
Tversky, A., Kahneman, D. (1974). Judgement under certainty: Heuristics and 
biases. Science, 185, 1124-1131. 
Uriz, J., Antelo, M., Zalba, S., Ugalde., N. and Corcoz, P. (2011). Improved 
traceability and transfusion safety with a new portable computerized system in a 
hospital with intermediate transfusion activity. Blood Transfusion, 9,172–81. 
Varney, S. (2003). The annual cost of blood transfusion in the UK. Transfusion 
Medicine, 13, 205-218. 
Verret, C. (1998). Evaluation of aa tracking system for labile blood products in the 
Midi-Pyrenes region. Transfusion Clinique et Biologique, 5, 275-282. 
Vincent, C., Stanhope, N., and Crowley-Murphy, M. (1999). Reasons for not 
reporting adverse incidents: An Empirical study. Journal of Evaluation in Clinical 
Practice, 1, 13-21. 
Wenz, B., (1991). Improvement in transfusion safety using a new blood unit and 
patient identification systems as part of safe transfusion practice. Transfusion, 31, 
401–403. 
 121 
 
Wessel, R. (2006) German clinic uses RFID to track blood. RFID Journal, retrieved 
from http://www. Rfidjournal.com/article/view/2169. 
Whitehead, S., Kenny-Siddique, S., Scott Y, Parker, P.I., Hardy, J. and Wallis, J.P. 
(2003). „Tag and label‟ system for checking and recording of blood transfusions. 
Transfusion Medicine, 13(4), 197-204. 
Williamson, L. (2002). Transfusion hazard reporting: powerful data, but do we know 
how best to use it. Transfusion, 42, 1249-1252. 
World Health Organisation (2006). The clinical use of blood: Handbook. World 
Health Organization. 
Zapt D. and Reason J. (1994). Introduction to error handling. Applied Psychology. 
43, 427-432. 
 122 
 
  
